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Abstract 
Venous thromboembolism (VTE) is a serious health concern of patients undergoing 
orthopedic surgery. Analysis of the study site semiannual reports from January 2014 
through March 2015 indicated 10 VTE events in 546 orthopedic cases. The community 
hospital was classed as an outlier performing in the bottom 10th percentile when 
compared to other hospitals. To standardize the ordering of VTE prophylaxis, the hospital 
developed a postoperative electronic VTE order set. The purpose of this project was to 
assess the difference in orthopedic VTE occurrences in the postoperative total hip 
arthroplasty (THA) patients before and after the implementation of the electronic VTE 
order set. The goal of the project was to use an electronic retrospective chart review to 
evaluate if the order set implementation influenced the adherence to ordering mechanical 
and pharmacological prophylaxis in the THA patient. Differences in the ordering of VTE 
prophylaxis and VTE outcomes were evaluated using a retrospective review of 325 
preimplementation order set cases and 406 postimplementation order set cases. This 
evaluation demonstrated that appropriate pharmacological prophylaxis ordering increased 
and orthopedic VTE occurrences decreased after the standardized electronic order set was 
implemented. Social change occurred through the empowerment of clinicians when 
empirical evidence was provided for use at the point of care, which positively impacted 
patient outcomes undergoing a common surgical procedure. VTE is no longer considered 
a routine postoperative orthopedic complication as technology-enabled solutions have 
proven to be appropriate tools to combat and prevent postoperative VTE complications.  
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Section 1: Nature of the Project 
Introduction 
Venous thromboembolism (VTE) poses a significant health and economic burden 
in U.S. hospitals (Merli, Ferrufino, Lin, Hussein, & Battleman, 2008). Orthopedic 
procedures have been found to have the highest prevalence of deep vein thrombosis when 
compared to other surgical procedures (Takai et al., 2013). The American College 
Surgeons National Surgical Quality Improvement Project (ACSNSQIP) 2014 Semiannual 
Report for the time period of January 2014–March 2015 reported 10 VTE events in 546 
orthopedic cases. Based on the orthopedic VTE outcomes data, the study site hospital  
was classed as an outlier performing in the bottom 10th percentile when compared to 
other organizations.  
Several years ago, the organization planned to improve orthopedic VTE outcomes 
by standardizing practice with electronic order sets. Due to a series of unfortunate 
circumstances, electronic order set activity for orthopedics was abruptly stopped. After 
leadership changes and new priorities, the electronic order set project began again with 
momentum to improve VTE outcomes. In July of 2014, the organization implemented 
computerized provider order entry (CPOE) order sets for the orthopedic service line. The 
purpose of this project was to assess the difference of orthopedic VTE occurrences in the 
postoperative total hip arthroplasty (THA) patient before and after implementation of the 
electronic VTE order set. In this study, I will discuss the factors that contributed to an 
increase in VTE, the nature of the project, and provide a solution to decrease the 
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incidence of VTE. In Section 1, I will discuss the context of the problem, project 
objectives, project questions, the significance of the project, implications for social 
change, and the assumptions and limitations. 
Background and Context 
The study site hospital organization is a regional tertiary facility comprised of 450 
acute care beds and that employs over 900 nurses and a total of 4,500 employees. The 
hospital earned Magnet designation in 2005 and received redesignation in 2009 and 2015 
by the American Nurses Credentialing Center. The community identifies the organization 
as a quality health care leader due to the fact it has received quality awards such as high 
ranking in orthopedics by the U.S. News and World Report, Thomson Reuters Top 100 
Cardiovascular Hospitals, Blue Distinction Award for Treatment of Complex and Rare 
Cancers, Heart and Stroke Emergency Center Designation, Percutaneous Coronary 
Intervention by Accreditation for Cardiovascular Excellence, and Best Hospital of the 
Capital Region.  
The organization underwent considerable change due to a local merger with three 
smaller acute care hospitals, while being simultaneously involved in a large enterprise-
wide consolidation. The enterprise consolidation had established a ministry that employs 
over 80,000 associates. The community hospital organization continues to focus on 
delivering the highest quality comprehensive continuum of integrated health care services 
in the region. 
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The organization has been challenged with the integration of CPOE within their 
patient care delivery model. Due to a higher than expected VTE rate, the orthopedic 
specialty was chosen by the organization to implement electronic order sets. The ultimate 
goal of CPOE was to standardize postoperative VTE prophylaxis ordering across the 
specialty to reduce VTE outcomes in the orthopedic patient. The absence of standardized 
electronic VTE order sets resulted in wide variation of VTE prophylaxis ordering on 
paper-based order sets. Within the paper-based order set, a section was dedicated to VTE 
prophylaxis. Some prophylaxis orders were predefined and other orders had blank lines 
for providers to write in orders. Inconsistencies in the order sets resulted in varied VTE 
prophylaxis ordering by providers. A number of factors will be discussed that contributed 
to an increase in the rate of VTE in postoperative orthopedic patients.  
Under the guidance of the enterprise, physician division chiefs, clinicians, and key 
subject matter experts across 19 acute care hospitals came together to standardize the 
postoperative orthopedic order set. The chief of orthopedics presented a persuasive 
argument to design the electronic order set to be all inclusive and support the ordering of 
VTE quality measures, which was supported by his orthopedic colleagues and 
interdisciplinary team. Through this process, relationships across the hospital system 
were fostered and strengthened within orthopedics. By the end of the order set design 
sessions, the orthopedic teams were pleased with their final product and were anxious to 
see the content be deployed in the electronic health record.  
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Weeks prior to releasing the order set for testing it was announced that the entire 
enterprise team was no longer with the system office. The order set project had come to 
an abrupt stop. Over the next couple of months, a new team was brought on-board to get 
the project back on track. The philosophy of the new team was different. They did not 
support an all-inclusive order set and insisted the order sets be pared down to specific 
content and be supplemented with additional modular order sets.  
Without input from key stakeholders, the new system office leaders pared down 
the order set content and provided it to the chief of orthopedics. The VTE prophylaxis 
orders had been removed from the larger order set and were moved to a subspecialty 
folder named VTE prophylaxis that was not linked to the postoperative orthopedic order 
set. The format was very concerning to the chief of orthopedics because it would require 
the clinician to remember to use the VTE order set that is in a different area than the 
postoperative orthopedic order set. The chief of orthopedics did not agree with order set 
version and declined to accept and implement the electronic order set.  
Eighteen months later, with a new chief of orthopedics the organization called 
upon the leader to implement CPOE. CPOE was necessary for two reasons. First, the 
VTE rate was higher than expected due to variation with paper orders. The pharmacy 
department reported receiving paper-based orders without VTE prophylaxis being 
ordered. When recognized, the pharmacy and nursing staff had to call providers for 
resolution. Computerized order entry offered the opportunity to standardize VTE 
prophylaxis ordering practices across orthopedics and improve VTE outcomes. The 
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second reason was to assist the organization to meet Meaningful Use (MU) II. For 
organizations to meet MU II, 60% of all medication orders had to be entered using CPOE 
(Centers for Medicare & Medicaid Services [CMS], 2012). Electronic medication orders 
were hovering at 48% which was below the 60% target. The significant volume of 
orthopedics patients would increase electronic medication orders above the target. The 
hospital organization convinced the system office to permit orthopedics to design a 
custom mega order set to meet their needs.    
During the development of the organization’s comprehensive postoperative 
orthopedic order set, the content design team incorporated VTE prophylaxis order set 
content for use in CPOE. The VTE prophylaxis content was developed with an 
interdisciplinary team by referencing the latest national guidelines from the American 
Academy of Orthopedic Surgeons (AAOS) and the American College of Chest 
Physicians (ACCP). To ensure medications within the VTE prophylaxis order set were 
well designed, the Institute for Safe Medication Practice’s guidelines for order sets served 
as a style guide for the organization. The electronic order set content was vetted by the 
chief of orthopedics and the orthopedic interdisciplinary team. After several edits, the 
content was approved, signed off by the chief of orthopedics and submitted to the 
enterprise health system. The order set was approved and built within the clinical 
information system. Orthopedics went live with CPOE in July of 2014.  
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Problem Statement 
The postoperative orthopedic VTE data derived from the hospital’s ACSNSQIP 
2014 Semiannual Report for the time period January 2014 to March 2015 reported 10 
VTE events in 546 orthopedic cases. Based on the orthopedic VTE events reported, the 
organization was performing in the bottom 10th percentile (National Surgical Quality 
Improvement Project (NSQIP), 2015). Variation with paper-based order sets contributed 
to an increase in VTE, so to standardize practice, in July of 2014 the organization 
implemented CPOE to decrease orthopedic VTE outcomes. Since CPOE was 
implemented, orthopedic VTE outcomes were higher than expected. It was been 
determined that the electronic VTE prophylaxis protocol was not consistently used by 
providers. The orders were entirely skipped or only a portion of the protocol may be 
ordered. Both nursing and pharmacy identified errors of commission or omission with 
VTE prophylaxis. The organization did not know what the negative impact of the 
electronic order set was on the incidence of VTE.  
The National Surgical Quality Improvement Project (NSQIP; n.d.) is a nationally 
benchmarked, clinical, risk-adjusted, and outcomes-based program to measure and 
improve care across surgical specialties nationally. The hospital organization’s quality 
improvement plan initiative was to achieve a national benchmark performance in the 90th 
percentile for variation prophylaxis ordering practices. Since the implementation of the 
electronic VTE order set in July 2014, the organization did not assess if technology was 
contributing to an increase or decrease in the number of orthopedic VTE events. It was 
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important for the organization to appraise if there were any unintended consequences 
posed by not using the order set properly.  
Purpose Statement 
The purpose of this project was to assess the difference of orthopedic VTE 
occurrences in the postoperative THA patient before and after the implementation of the 
electronic VTE order set. In July 2014, the organization implemented electronic order 
sets for the postoperative orthopedic patient population. In an effort to align the electronic 
VTE order set content with the most recent clinical practice guidelines established by the 
AAOS, ACCP, and CMS MU requirements, the VTE prophylaxis order sets were 
embedded into the comprehensive admission postoperative orthopedic order set. The all-
inclusive or mega order set approach was designed to support accurate ordering practices 
without having to leave the order set. Additionally, the approach was developed to 
augment clinician workflow and to encourage the ordering of important care 
requirements such as VTE prophylaxis for all postoperative orthopedic patients.  
The NSQIP VTE events that occurred between January 2014–March 2015 
comprised paper-based orders sets prior to July 1, 2014 and electronic order sets 
thereafter. During the electronic order set go-live in July 2014, clinical informatics 
nurses’ at-the-elbow support was embedded in the Post Anesthesia Care Unit (PACU) to 
hardwire the new electronic order entry process and workflow for orthopedic providers. 
Adapting to new electronic workflow took time for clinicians. The transition from paper 
to electronic order entry resulted in both paper-based and electronic order entry of VTE 
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prophylaxis until the new workflow was hardwired and adopted. Order set utilization 
rates measured by the hospital demonstrated strong adoption of CPOE by the providers; 
however, the organization had not mandated providers to use CPOE. 
Project Objectives 
I had two project objectives for this DNP project. My first objective was to 
evaluate if technology influenced the adherence to ordering of mechanical prophylaxis in 
the THA patient. I reviewed each THA case to assess the adherence to ordering 
mechanical prophylaxis. Ordering adherence was measured by developing a tool that 
included patient demographic information and the type of mechanical prophylaxis 
ordered. To assess aspects of mechanical VTE guidelines, a comparison of the percent of 
adherence before and after implementation of the order set was calculated to evaluate if 
technology was affecting VTE occurrences.  
My second objective was to evaluate if technology influenced the adherence to 
ordering pharmacological prophylaxis in the THA patient. I measured ordering adherence 
by developing a tool that included patient demographic information and the type of 
pharmacological prophylaxis ordered. To assess aspects of pharmacological VTE 
guidelines, a comparison of the percent of adherence before and after implementation of 
the order set was calculated to evaluate if technology is affecting VTE occurrences.  
In this project, I defined the electronic VTE order set preimplementation period as 
January 1–June 30, 2014. The electronic VTE order set postimplementation period was 
defined as January 1–June 30, 2015. All THA cases during the two time periods defined 
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were provided by Stryker. Stryker is a contracted vendor that specializes in collecting 
patient reported outcomes and extracting important hospital metrics into a dashboard to 
evaluate opportunities for process improvement (Stryker Performance Solutions, 2013).  
White and Dudley-Brown (2012) affirmed that outcomes data are crucial for 
providers to better understand the effects their services have on the patients they provide 
care for. The hospital organization’s latest orthopedic VTE outcomes performance 
suggested there was a problem with VTE occurrences in the postoperative THA patient. 
After the implementation of the electronic order set, the anticipated outcomes included: 
(a) an increase in the ordering of VTE prophylaxis in the post-operative THA patient, (b) 
an increase in the adherence to mechanical and pharmacological prophylaxis guidelines 
in the postoperative THA patient, and (c) a decrease in VTE occurrence for postoperative 
orthopedic THA patients. My review of the VTE outcomes assisted in the analysis of 
technology strategies to support the translation of the latest VTE guideline 
recommendations into evidence-based practice.  
Project Questions 
Given the objectives of the project, I developed the following four questions to 
guide the study:  
1. “What is the difference in the ordering of VTE prophylaxis before and 
after implementation of the electronic order”?  
2. “What is the difference in ordering of mechanical prophylaxis before and 
after implementation of the electronic order set”?  
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3. “What is the difference in the ordering of pharmacological prophylaxis 
before and after implementation of the electronic order set”?  
4. “What is the difference in orthopedic VTE occurrences before and after 
implementation of the electronic order set”? 
During the development of the electronic order set content, there was debate over 
the most appropriate prophylaxis interventions for the THA patient. While the AAOS and 
ACCP guidelines were utilized to develop the electronic VTE prophylaxis order set, the 
grade of evidence for some recommendations were stronger than others, limited, or 
inconclusive. An evaluation of the electronic VTE order set compared to the 
recommendations of both national organizations was needed to ensure the order set was 
aligned to support clinicians in adhering to evidence-based practice. Completing an 
analysis of postoperative THA patients that developed a VTE was beneficial to assess 
common themes contributing to the development of VTE. Inconsistencies in the ordering 
of VTE prophylaxis may have influenced providers to adhere to the guidelines of one 
nationally recognized organization over another and alter their current VTE prophylaxis 
regimens.   
Significance of the Project 
When an organization commits to the philosophy of evidence-based practice, they 
are positioning themselves to deliver high quality care that is cost effective (White & 
Dudley-Brown, 2012). Despite good evidence, it is difficult work to drill into practice 
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changes that may improve patient safety. Within systems of care, knowledge translation 
needs to occur (White & Dudley-Brown, 2012).  
According to Pronovost et al. (2009), “the boundaries between safety and the 
broader concept of quality remain poorly defined” (p. 330). In an effort to clarify broad 
clinical and policy domains that link to a safety scorecard, Pronovost et al. developed a 
Framework for Patient Safety Research and Improvement. The five framework domains 
include evaluating progress in patient safety, translating evidence into practice, 
measuring and improving culture, identifying and mitigating hazards, and evaluating the 
association between organizational characteristics and outcomes (Pronovost et al., 2009). 
Furthermore, Pronovost et al. argued that most research funding is spent on 
understanding disease mechanisms while there has been little research dedicated to 
identify effective, efficient, and safe delivery of care to patients.  
Doctoral-prepared nurses must be prudent financial stewards to reduce the cost of 
care for patients and health care organizations. Expanding an individual’s scope of 
knowledge related to the economics of healthcare will require continuous appraisal of the 
literature to stay current with newly proposed financial models such as value-based 
purchasing, which incorporate safe reliable care delivery where value is a function of 
both quality and cost (CMS, 2014a). Using technology solutions to assist in decreasing 
VTE occurrences in the postoperative THA patient improved quality outcomes, 
decreased cost, and ensured care that was both dependable and reliable. 
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Reduction of Gaps 
The Agency for Healthcare Research and Quality (AHRQ; 2014a) reported deep 
vein thrombosis (DVT) may increase hospital length of stay by 2 to 5 days and result in 
excess costs of about $7,500. Pulmonary embolism (PE) can increase hospital length of 
stay by more than 5 days, result in an intensive care unit admission, and incur additional 
costs of more than $10,000 (AHRQ, 2014a). After a major surgical procedure, the risk of 
DVT and PE is approximately 20% for patients that did not receive prophylaxis (Baser, 
2011). If patients do not receive the appropriate prophylaxis, patient safety issues, poor 
outcomes, and financial implications for the organization could be incurred. 
The number one strategy to improve patient safety for patients at risk of VTE is 
the use of appropriate prophylaxis (AHRQ, 2014a). To ensure appropriate prophylaxis is 
utilized, clinicians must adhere to clinically appropriate evidence-based methods of 
prophylaxis. The AAOS (2011b) and ACCP (2012) both provide lengthy guidelines on 
the prevention and management of VTE prevention including suggestions for individual 
assessment of patients when choosing the specific thromboprophylaxis strategy. The 
hospital organization did not evaluate if the electronic VTE prophylaxis order set content 
was aligned to support the provider in selecting the most appropriate thromboprophylaxis 
based on AAOS or ACCP guidelines. Additionally, cases were not reviewed to identify 
themes for patients that developed a VTE following elective hip arthroplasty. 
A retrospective content review of VTE cases for the elective hip arthroplasty 
population can provide insight into the adherence to national guidelines, 
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thromboprophylaxis ordering patterns, and assist in the detection of errors of omission 
and commission. To determine if the actual practice of thromboprophylaxis ordering was 
consistent with AAOS and ACCP recommendations, I expected the project to reveal 
where variation and/or deviation from the order set existed when ordering VTE 
prophylaxis, the patient specific risk of VTE, and if the prophylaxis was aligned with 
either AAOS or ACCP evidence-based guidelines.  
Implications for Social Change 
VTE is a serious health concern. Beckman, Hooper, Critchley, and Ortel (2010) 
acknowledged known risk factors such as increased age, immobility, surgery, and obesity 
are a public health problem that needs attention. In 2007, within six European countries, a 
total of 465,715 cases of DVT and 295,982 cases of PE were estimated (Cohen et al., 
2007). Of the combined cases, deaths related to VTE were 370,012 or 49% (Cohen et al., 
2007). More recent data in the United States indicates 900,000 people are affected by 
VTE each year and nearly 300,000 die from the disease (Dasta et al., 2015). By 2050, the 
number of adults with VTE is estimated to double to 1.82 million in the United States 
(Dasta et al., 2015). Despite efforts to increase awareness of VTE, health care providers 
can underrecognize the condition.  
The ultimate goal of this project was to assess if the electronic order set 
influenced the provider’s adherence to ordering VTE prophylaxis and decreased VTE in 
the THA patient. VTE is preventable and needs to be taken seriously. With this project, I 
sought to inform providers that inconsistent use of the order set contributed to a delay or 
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omission in prophylaxis ordering. Providers needed to assess their current practice and 
consider effective approaches to promote best practice prophylaxis use and prevent 
patient harm resulting from VTE.  
The social change realized across the organization was that unsafe medical care is 
not acceptable. Patients should not be harmed when receiving care in the organization. It 
was necessary for healthcare providers to learn more about the burden and causes of VTE 
and adopt best practices to ensure safe patient care. Accepting VTE as a routine 
postoperative surgical or orthopedic complication is no longer acceptable. Raising public 
awareness and developing a comprehensive public health approach that leverages 
technology to combat and prevent VTE could reduce complications and unnecessary 
deaths. Developing a comprehensive training module for clinicians, patients, and families 
on VTE prevention could be the first step to raise awareness and engage the public to 
understand why VTE prevention is critical for improvements in patient outcomes. 
15 
   
Definition of Terms 
In the healthcare field, many terms are commonly used. Depending on the context 
of the information, terms can be misinterpreted or have more than one meaning. In the 
following subsection, I will define the terms referenced throughout the project study:  
American Recovery and Reinvestment Act (ARRA): An act  passed in 2009,  that 
earmarked $22 billion for the adoption of electronic health records (EHRs), with a goal of 
100% adoption in all practice settings by the year 2014 (The White House, 2009).  
Computerized provider order entry (CPOE): The process of entering  medication 
orders and other physician’s instructions electronically using a computer-based system  to 
ensure standardized, legible, and complete orders (Al-Dorzi et al., 2011, p.1).  
Deep vein thrombosis (DVT): Formation of one or more blood clots in the body’s 
large veins, most commonly the lower leg or calf (Office of the Surgeon General; 
National Heart, Lung, and Blood Institute, 2008).  
Electronic health record (EHR): An electronic version of a patient’s medical 
history that is maintained by the provider over time and may include all of the key 
administrative clinical data relevant to that persons care under a particular provider, 
including demographics, progress notes, problems, medications, vital signs, past medical 
history, immunizations, laboratory data, and radiology reports (CMS, 2012, para. 1).  
Health information technology (HIT): A broad concept that encompasses an array 
of technologies to store, share and analyze health information (U.S. Department of Health 
& Human Service, 2013). 
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Hospital acquired condition (HAC): A medical condition or complication that a 
patient develops during the hospital stay, which was not present on admission (CMS, 
2015b). 
Intermittent pneumatic compression device (IPCD): An inflatable cuff wrapped 
around the leg with an electrical pneumatic pump that inflates the cuff with air to increase 
femoral venous blood flow and venous emptying (Fujisawa, Naito, Asayama, Kambe, & 
Koga, 2003);   
Meaningful use (MU): Using certified EHR technology to improve quality, reduce 
health disparities, engage patients and family, improve care coordination and population 
health, and maintain privacy and security of patient health information (U.S. Department 
of Health & Human Services, 2015).  
Order set: Grouping of common predefined orders for a particular disease state 
(Cowden, Barbacioru, Kahwash, & Saltz, 2003). 
Pulmonary embolism (PE): A portion of a blood clot breaks loose and travels into 
the blood stream, first to the heart and then to the lungs, where it can partially or 
completely block a pulmonary artery or one of its branches (Office of the Surgeon 
General ; National Heart, Lung, and Blood Institute, 2008). 
Total hip arthroplasty (THA): A surgical procedure where the damaged bone and 
cartilage is removed and replaced with prosthetic components (American Academy of  
Orthopedic Surgeons, 2015).  
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Venous thromboembolism (VTE): DVT and PE are grouped together and referred 
to as VTE (Office of the Surgeon General; National Heart, Lung, and Blood Institute, 
2008). 
Assumptions and Limitations 
 As I developed and conducted the project, it was important to plan for and address 
assumptions. Assumptions are external factors that have the potential to influence the 
success of the project but are outside the control of the project leader (White & Dudley-
Brown, 2012). My first assumption for this DNP project was that the order set has a 
positive influence on provider ordering practices for VTE prophylaxis. A second 
assumption was the order set has been fully adopted by the providers with 100% 
utilization of the electronic order set. My third assumption was that when used properly, 
the order set will decrease VTE in THA patients.  
Limitations of the project included the fact that a 6-month period was reviewed 
before and after the implementation of the electronic order set to assess the difference in 
the occurrence of orthopedic VTE. A longer time period to evaluate the differences in the 
occurrence of orthopedic VTE may have been beneficial. Another limitation was the 
hospital organization had not mandated providers use CPOE. Encouraging providers to 
use CPOE was important to the project. Educating providers on measures of efficiency, 
such as medication turnaround time or time to first dose of prophylaxis, will be essential 
to demonstrate adoption of the order set (Classen, Avery, & Bates, 2007). A third 
limitation was when using the order set there was no alerting mechanism to the provider 
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if VTE prophylaxis was not ordered. The project identified that additional clinical 
decision support may be beneficial to ensure prophylaxis has been ordered.  
Summary 
Although preventable, VTE continues to be a major concern in the United States. 
Following orthopedic surgery, VTE is the leading cause of hospital readmission (Johnson 
& Riley, 2012). With the purpose of decreasing VTE, the hospital organization study site 
chose to standardize and drive practice improvements with electronic order sets. In this 
project, I conducted a comparison of VTE occurrences before and after implementation 
of the order set. The results of the project informed the organization that the electronic 
order set is working as designed to improve practice. The analysis I conducted revealed 
mechanical prophylaxis remained the same while the pharmacological prophylaxis 
increased, which resulted in a decrease of orthopedic VTE outcomes. Evaluating the 
impact of electronic order sets has led to safer and more reliable hospital and postacute 
care for orthopedic patients.  
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Section 2: Review of Scholarly Evidence 
Introduction 
Section 2 will include the literature review. In this specific literature review, I will 
discuss the pathophysiology, assessment, and risk factors of VTE in the postoperative 
orthopedic population. The past lack of evidence to recommend chemical prophylaxis 
and the more current emerging evidence demonstrating the efficacy of aspirin, 
enoxaparin, and IPCDs to prevent VTE in postoperative joint replacement surgery will 
also be discussed. The general literature review will also include a focused review of the 
AAOS and ACCP VTE prophylaxis recommendations for aspirin, enoxaparin, and IPCDs 
in the postoperative orthopedic population. The AAOS and ACCP are two nationally-
recognized organizations that publish evidence-based clinical practice guidelines on 
preventing VTE disease in patients undergoing elective joint replacement surgery. In the 
general literature review, I will also discuss how CPOE and order sets can standardize 
VTE care, decrease variation, and improve patient outcomes. Lastly, I will use an 
accountable care organization (ACO) model to explore the problem of VTE in the 
postoperative orthopedic THA patient population and foster shared accountability among 
providers for the quality and cost of care. 
Search Strategy 
To perform the literature review, I accessed the following databases and libraries: 
AHRQ, OVID Technologies, Medline, PubMed Medline, Institute of Medicine (IOM), 
ProQuest Nursing and Allied Health Sources, Cumulative Index to Nursing and Allied 
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Health Literature (CINAHL), EBSCOhost, AAOS, ACCP, and the National Guideline 
Clearinghouse. Key search terms for the literature review included: venous 
thromboembolism prophylaxis in orthopedic surgery, venous thromboembolism in total 
joint arthroplasty, venous thromboembolism in total hip arthroplasty and replacement, 
chemical prophylaxis in orthopedics, aspirin use in orthopedics, enoxaparin use in 
orthopedics, mechanical prophylaxis, intermittent pneumatic compression devices, 
clinical information systems, physician order entry, computerized provider order entry, 
electronic order sets, venous thromboembolism orthopedic AND hip arthroplasty, aspirin 
AND orthopedic surgery, aspirin AND total hip replacement, enoxaparin AND 
orthopedic surgery, enoxaparin AND total hip replacement, mechanical prophylaxis 
AND total hip replacement, and electronic order sets AND venous thromboembolism 
prophylaxis OR total hip arthroplasty. 
In the review, I located 65 articles. Twenty-five articles were rejected due to lack 
of pertinent information to the project. Forty studies I found included in the literature had 
publication dates from 1986 to 2015. The methodologies in the articles included classical, 
comparative, meta-analysis, randomized control trials, review, and systematic reviews. 
The content included controversy over using chemical prophylaxis versus aspirin to 
prevent VTE in major orthopedic surgery, the use of enoxaparin and intermittent 
pneumatic compression devices in the prevention of postoperative VTE in major 
orthopedic surgery, AAOS and ACCP national guidelines and recommendations to 
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prevent postoperative VTE in major orthopedic surgery, and the benefits of clinical 
information systems and electronic order sets to standardize physician practice.   
Review of Literature 
The clinical practice of prescribing thromboprophylaxis by orthopedic surgeons 
following THA surgery is not standardized. Within the last 10 years, hospital oversight 
groups require hospitals to monitor and report orthopedic VTE rates (AHRQ, 2014a). 
Improving VTE rates has prompted hospitals to work with orthopedic surgeons to 
implement evidence-based practices that can be standardized and hard wired within 
clinical information systems (Cohen et al., 2007). Guidelines published by the AAOS and 
ACCP are broad and provide multiple options for pharmacological prophylaxis. After 
reviewing the guidelines, orthopedic surgeons may have differing opinions on which type 
of chemical prophylaxis to order following surgery. I will discuss the literature produced 
within the last 20 years as it has long been debated.   
Pathophysiology of Venous Thromboembolism (VTE) 
Abnormal blood flow, blood vessel wall, and blood clotting components, known 
jointly as Virchow’s triad can cause the formation of thrombus (Turpie, Chin, & Lip, 
2002). Prolonged periods of immobility or confined bed rest can result in blood flow 
abnormalities or venous stasis (Turpie, Chin, & Lip, 2002). One of the extrinsic factors 
triggering the clotting cascade is damage to the epithelial cell lining if the blood vessel 
(Snyder, 2008). As blood clots develop “the damaged endothelium attempts to maintain 
vascular integrity by adhesion and aggregation of platelets” (Snyder, 2008, p. 225). As 
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clotting progresses, the final step is the formation of thrombin, which leads to the 
conversion of fibrinogen to fibrin and the formation of a fibrin clot (Arcangelo & 
Peterson, 2006).  
Pain, erythema, tenderness, and swelling of the affected extremity are common 
signs of DVT. DVT of the lower extremity is usually swollen with the circumference of 
the calf larger than the unaffected calf (Turpie, Chin & Lip, 2002). Compression 
ultrasonography is the noninvasive test of choice to confirm the diagnosis of clinically-
suspected DVT (Turpie, Chip & Lip, 2002). Sudden shortness of breath, pleuritic chest 
pain, or collapse with shock in the absence of other causes are common signs of PE 
(Snyder, 2008). If thrombus separate from the vessel wall, it becomes an embolus 
(Turpie, Chin & Lip, 2002). The clot travels through the circulation until it lodges in a 
blood vessel where the blood flow is blocked and tissues or organs are deprived of 
oxygen (Snyder, 2008). PE is one the most serious complications in the orthopedic 
surgery population (AHRQ, 2014b). Pulmonary angiography testing is the gold standard 
to confirm the diagnosis of clinically-suspected PE (Turpie, Chin & Lip, 2002).   
Venous Thromboembolism (VTE) Assessment and Risk Factors  
With major orthopedic surgery, VTE is considered an important complication that 
is associated with significant morbidity and mortality (Cionac Florescu et al., 2013). 
Orthopedic patients are more vulnerable to VTE due to several prothrombotic processes 
such as: coagulation activation from tissue and bone injury, venous injuries, heat due to 
cement polymerization, reduced emptying intra-or postsurgery, and immobilization 
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(Cionac Florescu et al., 2013). In the absence of prophylaxis almost half of the patients 
undergoing elective total hip or knee replacement surgery develop VTE (Anderson & 
Spencer, 2003). PE is the most common postoperative complication in THA and is 
attributed to half of the postoperative deaths (Cionac Florescu et al., 2013).  
Unique to orthopedic surgery is that the VTE risk period begins at surgery and 
extends beyond hospitalization into the postacute care setting, which prolongs the period 
of thromboprophylaxis (Cionac Florescu et al., 2013). Thrombus formation can take 
several days or weeks and is often detected days or weeks after hospital discharge 
(Snyder, 2008). Cohen et al. (2008) argued that despite the availability of evidence-based 
guidelines for VTE prophylaxis, assessment of patients who may be at risk is not 
consistently undertaken at both international and national levels. Currently, there is no 
way to predict which postoperative orthopedic patients will develop VTE. Educating 
patients and their care givers on the signs and symptoms of VTE may provide a public 
health benefit.  
Risk factors for VTE should be evaluated by the orthopedic surgeon prior to 
arthroplasty surgery. While the literature is not specific for VTE risk factors in THA 
patients, there is strong evidence of overall VTE risk factors that include age greater than 
50, myeloproliferative disorder, dehydration, congestive heart failure, active malignancy, 
hormonal replacement, moderate to major surgery, prior history of VTE, impaired 
mobility, inflammatory bowel disease, active rheumatic disease, sickle cell disease, 
estrogen-based contraceptives, central venous catheter, acute or chronic lung disease, 
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obesity, known thrombophilic state, varicose veins/chronic stasis, recent postpartum with 
immobility, nephrotic syndrome, and myocardial infarction (AHRQ, 2014a). The 
presence of these risk factors emphasizes the importance of individualized VTE risk 
assessment. A prior history of VTE and undergoing elective hip or knee arthroplasty 
surgery may present the highest risk of VTE in orthopedic patients (Cohen et al., 2007).  
An important aspect in the prevention and management of VTE is assessing 
patient risk for both VTE and bleeding in the preoperative period (Beckman, Hooper, 
Critchley, & Ortel, 2010). Data from the VTE assessment can be used to modify the type 
of VTE prophylaxis for optimal patient safety (Cohen et al., 2007). Regardless of patient 
factors, surgical procedure factors, such as length of surgery, presence of trauma, and 
orthopedic surgery, can have a significant impact on the risk of VTE (Dasta et al., 2015). 
Although no single VTE risk assessment has been prospectively validated as superior to 
another (AHRQ, 2014a), the Caprini VTE risk assessment is frequently used for surgical 
patients. I did not find a VTE risk assessment specifically tailored to orthopedic surgery 
patients in the literature. The Caprini VTE risk assessment is a point-based tool that is 
used to assess risk factors for the development of VTE in surgical patients (AHRQ, 
2014a). The results of the score can be used by providers to stratify VTE risk and 
determine the type of prophylaxis for surgical patients.  
Bleeding is considered a major potential complication of chemical prophylaxis 
and requires careful evaluation by the provider (Cohen et al., 2007). Types of VTE 
prophylaxis used during hospitalization include chemical and mechanical prophylaxis. 
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Chemical prophylaxis includes low-molecular-weight heparin, unfractionated heparin, 
vitamin K antagonist, fondaparinux, and antiplatelet agents (AHRQ, 2014a). Mechanical 
prophylaxis includes intermittent pneumatic compression, venous foot pumps, and 
graduated compression stockings (Cohen et al., 2008). Mechanical prophylaxis devices 
can reduce the formation of blood clots by increasing blood flow (Collins, MacLellan, 
Gibbs, MacLellan, & Fletcher, 2010). Pharmacological and mechanical prophylaxis can 
be used in combination for patients with increased VTE risk factors (AHRQ, 2014a).  
Traditionally, providers have been responsible for assessment and prescribing 
VTE prophylaxis, while nursing’s role has been limited (Collins et al., 2010). Nurses that 
are involved in direct patient care can have a pivotal role in the assessment and 
prevention of VTE. In the immediate postoperative period, nurses are providing direct 
patient care and conducting detailed patient assessments to ensure the patient is 
responding appropriately. If nurses are educated on the latest evidence-based practices in 
the assessment and prevention of VTE they can have a prominent role in changing 
practice to promote optimal patient outcomes.  
Lack of Evidence to Recommend Chemical Prophylaxis 
Warwick, Williams, and Bannister (1995) analyzed the records of 1,162 patients 
who had a primary or revision THR performed between 1990 –1991. The purpose of their 
study was to determine the frequency of fatal and nonfatal PE and DVT 6 months after 
surgery. Routine chemical prophylaxis was not used during this time; antiembolic 
stockings and early mobilization was the standard practice (Cohen et al., 2008). Of the 
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1,162 patients, four or .34% developed fatal PE, 14 or 1.2% developed symptomatic PE, 
and 22 or 1.89% developed DVT (Warwick et al., 1995). The researchers concluded that 
in the absence of routine chemical prophylaxis, the fatal PE rate was low after total hip 
replacement (THR) (Warwick et al., 1995). The results of the study did not provide 
sufficient evidence to recommend thromboprophylaxis after hospital discharge. The large 
cohort of 1,162 patients that were treated by 12 consultant surgical teams at one 
specialized center would be considered a strength of the study. Evaluating the results of 
this study could contribute to orthopedic surgeons’ reluctance to ordering chemical 
prophylaxis within the standardized electronic order set. The results of Warwick et al.’s 
study support this project because thromboembolism prophylaxis in total hip replacement 
surgery has been a controversial issue with orthopedic surgeons. Within the hospital 
organization study site, orthopedic surgeons had differing opinions over which agent to 
use routinely for chemical prophylaxis. To promote routine use of chemical prophylaxis 
an electronic order set was developed.  
Fender, Harper, Thompson, and Gregg (1997) found that the use of chemical 
prophylaxis did not affect the overall mortality or fatal PE rates. Of the 1,893 
arthroplasties, 1,226 or 64.8% received some form of chemical prophylaxis and 667 or 
35.2% received no chemical prophylaxis (Fender, Harper, Thompson & Gregg, 1997). 
For those with chemical prophylaxis, the mortality rate was 10 of 1,226 or .82% and 
seven of 667 or 1.05% for those without chemical prophylaxis (Fender, Harper, 
Thompson & Gregg, 1997). For those with chemical prophylaxis, the PE rate was 3 of 
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1,226 or .24% and 1 of 667 or .15% for those without chemical prophylaxis. The study 
concluded that with the use of chemical prophylaxis, there was no significant difference 
between mortality and PE rates. The type of chemical prophylaxis patients received is not 
reported in the study. Since patients were not randomized into a specific group with 
chemical prophylaxis there is no comparison of mortality and PE rates with other 
chemical prophylaxis agents. Evaluating the results of this study could contribute to 
orthopedic surgeon’s reluctance to ordering chemical prophylaxis within the standardized 
electronic order set. The study supports the controversial matter that chemical 
prophylaxis may not have an impact on the incidence of VTE. For orthopedic surgeons 
practicing in the 1990s, the literature was not conclusive in demonstrating the efficacy of 
routine use of chemical prophylaxis to prevent VTE in total hip replacement surgery. 
Given the controversial issues, the organization reviewed recent literature and guidelines 
to develop evidence-based electronic order sets.  
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Efficacy of Aspirin to Decrease Venous Thromboembolism  
During 1992 through 1998, 4,088 patients undergoing elective arthroplasty were 
randomized into the placebo-controlled group and into the aspirin group of the pulmonary 
embolism prevention (PEP) trial (PEP Trial Collaborative Group, 2000). The PEP study 
is considered a large and important study of aspirin after major orthopedic surgery. The 
purpose of the study was to prove or disprove if 160 mg of aspirin daily reduces the risk 
of PE and DVT (PEP Trial Collaborative Group, 2000). Of the 2,047 patients assigned to 
aspirin, 15 or .73% developed nonfatal DVT, eight or .39% developed non-fatal PE, and 
one or .05% developed fatal PE (PEP Trial Collaborative Group, 2000). Of the 2,041 
patients assigned to placebo, 19 or .93% developed nonfatal DVT, eight or .39% 
developed non-fatal PE, and two or 1% developed fatal PE. The results of the PEP trial 
demonstrated that aspirin decreases the risk of DVT and PE by at least one third (PEP 
Trial Collaborative Group, 2000). The PEP study (2000) confirmed aspirin was an 
effective means of chemical prophylaxis and could be used routinely for patients at high 
risk of DVT/PE. The study supports that aspirin is effective in the prevention of VTE in 
postoperative orthopedic patients and should be considered as a standard prophylactic 
treatment. The agent was added to the organization’s electronic order set as standard VTE 
prophylactic therapy for total hip replacement surgery.  
The Antiplatelet Trialists’ Collaboration (ATC) is a worldwide three-part 
overview of randomized trials of antiplatelet therapy. The authors used collaborative 
meta analyses to compare antiplatelet regimens. Part I and II of the ATC proved that 
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antiplatelet therapy, such as aspirin, reduces the risk of myocardial infarction, cerebral 
infarction and other arterial occlusion (Antiplatelet Trialists’ Collaboration, 1994).  
Part III of the ATC sought to determine the efficacy of antiplatelet therapy as 
prophylaxis to prevent DVT or PE in surgical and high risk medical patients (Antiplatelet 
Trialists’ Collaboration, 1994). Previously, aspirin had not been an accepted method of 
treatment to prevent DVT or PE. The study included 53 trials with a total of 8,400 
subjects who had an average of two weeks of antiplatelet therapy versus control in 
general or orthopedic surgery (Antiplatelet Trialists’ Collaboration, 1994). Also included, 
were nine trials with 600 patients of antiplatelet therapy versus control in other types of 
immobility and 18 trials with 1,000 patients receiving one antiplatelet regimen over 
another. For elective orthopedic surgery, 18 randomized trials with 1,154 patients were 
identified (Antiplatelet Trialists’ Collaboration, 1994). Elective orthopedic surgery 
patients that received aspirin therapy for two weeks observed a 49% reduction in DVT, 
while a reduction in PE of 51% was noted (Antiplatelet Trialists’ Collaboration, 1994). 
The ATC Part III (1994) substantiated that aspirin reduces both the incidence of DVT and 
PE in elective orthopedic surgery patients, traumatic orthopedic surgery and patients 
having general surgery. Bleeding complications were not consistently measured; 
however, each collaboration suggested when using aspirin the risk of bleeding is small. 
Aspirin has been shown to protect against DVT, PE, and other vascular events. 
Additionally, aspirin is well known, accessible, and provides a low-cost option for 
elective orthopedic surgery patients to prevent against VTE. The study supports that 
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when aspirin is used for VTE prophylaxis in elective orthopedic surgery patients, it is 
both effective in the prevention of VTE and does not increase the risk of bleeding 
postoperatively. Based on the evidence of this important study, aspirin was added to the 
electronic order set as standard VTE prophylaxis for total hip replacement surgery. 
The purpose of the Antithrombotic Trialists’ Collaboration (2002) meta-analysis 
review was to determine the effects of antiplatelet therapy in patients with high risk of 
vascular occlusive events. A total of 287 studies were evaluated comprising 135,000 
subjects to compare antiplatelet therapy versus control and 77,000 subjects in 
comparisons of different antiplatelet regimes (Antithrombotic Trialists’ Collaboration, 
2002). The results of the meta-analysis revealed that antiplatelet therapy protects against 
vascular events among patients with unstable angina, intermittent claudication, and atrial 
fibrillation (Antithrombotic Trialists’ Collaboration, 2002). Of the 287 studies, 32 trials 
which examined PE found that antiplatelet therapy reduced the risk of fatal and nonfatal 
PE by 25% among patients undergoing orthopedic surgery (Antithrombotic Trialists’ 
Collaboration, 2002). The study supports the efficacy of aspirin in reducing PE events for 
patients having orthopedic surgery. The evidence further supports aspirin as standard 
VTE prophylaxis in total hip replacement and was added to the electronic order set. 
Efficacy of Enoxaparin to Decrease Venous Thromboembolism 
Turpie et al. (1986) conducted a randomized controlled trial of a low-molecular 
weight heparin, enoxaparin to prevent deep vein thrombosis in patients undergoing 
elective hip surgery. Fifty subjects received enoxaparin and 50 received placebo. 
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Prophylactic treatment was begun postoperatively in the 50 subjects who received 
enoxaparin and the 50 who received placebo, and continued for 14 days. Thrombosis was 
identified in 6 of 50 or 12% in the enoxaparin group and in 21 of 50 or 42% in the 
placebo group. The results of the trial concluded that enoxaparin is an extremely effective 
and safe form of VTE prophylaxis for elective hip arthroplasty patients (Turpie et al., 
1986). Randomized control trials provide the strongest empirical evidence of a 
treatment’s efficacy, which affords physicians with the information to individualize 
patient treatments in clinical practice. The study supports the efficacy of enoxaparin in 
reducing VTE for patients having hip replacement surgery. Enoxaparin was added to the 
electronic order set as standard prophylaxis for total hip replacement patients that are 
identified to be at the highest risk of developing VTE.       
In 1988, a randomized, double blind placebo controlled study, sought to compare 
the efficacy and safety of enoxaparin and standard heparin for VTE prophylaxis after 
elective hip surgery (Planes et al., 1988). A total of 237 subjects were randomized into 
either active or control treatment. One hundred twenty-four subjects were randomly 
assigned to the active treatment arm and received enoxaparin 40mg subcutaneously 12 
hours prior to surgery and then daily for 14 days or until discharge from the hospital. One 
hundred thirteen subjects were assigned to the control treatment arm and received 
unfractionated heparin (UFH) 5,000 international units subcutaneously 2 hours before 
surgery and then every 8 hours for 14 days or until discharge from the hospital. For those 
receiving enoxaparin, deep vein thrombosis was identified in 15 of 120 or 12.5 % and 27 
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of 108 or 25% for those receiving UFH (Planes et al., 1988). It was concluded that 
treatment with daily enoxaparin significantly reduced the incidence of overall and 
proximal DVT than those treated with UFH three times a day (Planes et al., 1988). 
Randomized control trials provide the strongest empirical evidence of a treatments 
efficacy and assist physicians to modify clinical practice to improve patient outcomes. 
The study supports enoxaparin’s efficacy in reducing DVT without increasing the risk of 
bleeding. The agent was added to the electronic order set for total hip replacement 
patients identified at high risk of developing VTE.   
Levine et al. (1991) completed a double-blind, randomized, control trial 
comparing low molecular weight heparin (enoxaparin) with standard unfractionated 
heparin. The goal of the study was to evaluate the efficacy and safety of enoxaparin 
compared with heparin for the prevention of postoperative DVT in patients undergoing 
total hip replacement surgery. Six hundred sixty-five patients were randomized and 
received either enoxaparin 30 mg subcutaneously twice daily or standard heparin 7,500 
units subcutaneously twice daily (Levine et al., 1991). The treatments were started 12 to 
24 hours after surgery and continued for 14 days (Levine et al., 1991). Thrombosis 
occurred in 17.1% of the subjects that received enoxaparin and 19% of those given 
standard heparin (Levine et al., 1991). Bleeding complications occurred in 5.1% of 
subjects that received enoxaparin and 9.3% of subjects that received heparin (Levine et 
al., 1991). The study concluded that total hip replacement subjects who were 
administered enoxaparin had a lower rate of thrombosis and significantly less bleeding 
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than those that were administered heparin (Levine et. al., 1991). The study supports 
enoxaparin as an effective and safe agent in DVT prophylaxis for total hip replacement. 
Since the agent does not show evidence of increased bleeding complications it was 
included in the organization’s electronic order set.  
Bergqvist et al. (1996) conducted a prospective, randomized double-blind study 
for subjects undergoing elective hip replacement to evaluate whether anticoagulation for 
one month post-operatively with enoxaparin is more effective therapy than enoxaparin 
given only during the acute hospitalization period. Two hundred sixty-two subjects 
received prophylaxis against thrombosis with enoxaparin 40 mg subcutaneously daily 
during their hospitalization (Bergqvist et al., 1996). The first dose of enoxaparin was 
administered the evening prior to surgery. At discharge, subjects were randomly assigned 
to receive either enoxaparin or placebo once daily for 21 days (Bergqvist et al., 1996). 
The VTE incidence rate observed for the placebo group was 39% while the enoxaparin 
group was 18% (Bergqvist et al., 1996). The study concluded that extending prophylaxis 
with enoxaparin into the post-acute care setting significantly decreased VTE incidence in 
total hip replacement surgery (Bergqvist et al., 1996). Based on the results of the study, 
the organization’s VTE electronic order set recommends enoxaparin for at least 21 days 
after hospital discharge for total hip replacement surgery.  
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Efficacy of Intermittent Pneumatic Compression to Decrease Venous 
Thromboembolism 
Hull et al. (1990) completed a randomized trial to assess if calf and thigh 
compression devices were effective in preventing VTE after total hip replacement when 
compared with a control group that was given no prophylaxis. Thrombosis was identified 
in 77 of 158 or 49% of the control subjects versus 36 of 152 or 24% of subjects given 
intermittent compression (Hull et al., 1990). It was concluded that intermittent leg 
compression significantly decreased the frequency of thrombosis after total hip 
replacement surgery. Intermittent pneumatic compression devices were included in the 
organization’s electronic order set as part of standard VTE prophylaxis therapy for all 
patients following total hip replacement surgery.  
A prospective study of 502 total hip arthroplasty subjects conducted by Hooker, 
Lachiewicz, and Kelley (1999) sought to appraise the effectiveness of intermittent 
pneumatic compression in the prevention of VTE after total hip arthroplasty. All subjects 
had bilateral thigh-high anti-embolic stockings and intermittent pneumatic compression 
devices applied at the start of the procedure and were maintained throughout the post-
operative period except for personal hygiene or participating in physical therapy (Hooker, 
Lachiewicz, & Kelley, 1999). Lower extremity ultrasound discovered that 23 of 502 or 
4.6% of subjects developed an asymptomatic thrombosis, while 3 of 502 or .6% 
developed a symptomatic pulmonary embolism confirmed with a lung scan (Hooker et 
al., 1999). Hooker et al. (1999) reported 1% of subjects experienced minor bleeding 
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complications. It was concluded that the lower prevalence of both DVT and PE with 
intraoperative and postoperative intermittent pneumatic compression is comparable with 
that associated to chemical prophylaxis (Hooker et al., 1999). A weakness of the study 
was that it examined elastic compression stockings and intermittent pneumatic 
compression as prophylaxis against VTE, which makes it difficult to determine if one 
mechanical therapy is superior to another. The organization elected to add intermittent 
pneumatic compression devices to their electronic order set as standard VTE prophylaxis 
therapy following total hip replacement surgery.    
Fujisawa, Naito, Asayama, Kambe, and Koga (2003) compared two different 
types of intermittent pneumatic compression devices for the prevention of thrombosis and 
leg swelling following total hip replacement surgery. Fifty-eight subjects were assigned 
to the calf-thigh pneumatic compression group and 63 were assigned to the plantar 
compression group (Fujisawa, Naito, Asayama, Kambe, & Koga, 2003). Seven days after 
hip replacement surgery, the circumference of the thigh was measured for both groups. 
The calf-thigh circumference ratio averaged 1.22% and the plantar averaged 3.19% 
(Fujisawa et al., 2003). The study concluded that calf-thigh pneumatic compression is 
more effective than plantar compression in decreasing swelling and is less likely to 
contribute in causing thrombosis due to decreased vein flow (Fujisawa et al., 2003). The 
organization and orthopedic surgeons agreed to add intermittent pneumatic compression 
devices rather than plantar compression to the electronic order set.  
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Ben-Galim et al. (2004) studied the efficacy of a battery operated and mobile 
intermittent pneumatic compression device compared to a commonly used intermittent 
compression device that was not portable. Twenty-five subjects were randomized into the 
mobile compression device and the nonmobile compression device to compare the 
efficacy of the device in preventing DVT after joint replacement surgery (Ben-Galim et 
al., 2004). Both groups also received the routine treatment of heparin 5,000 units 
subcutaneously twice a day for six days following surgery (Ben-Galim et al., 2004). 
Doppler ultrasounds were performed on post-operative day 6 for all patients and there 
were no reports of DVT or PE discovered in any of the 50 patients. The study concluded 
that mobile compression devices were not superior to nonmobile compression devices 
and both devices are effective in the prevention of VTE for patients after total joint 
replacement surgery (Ben-Galim et al., 2004). The organization and orthopedic surgeons 
decided that nonmobile intermittent pneumatic compression devices were appropriate for 
the postoperative total hip VTE electronic order set.  
General Review of Literature 
Venous thromboembolism, a disease process that encompasses DVT and PE 
(Baser, Sengupta, Dysinger, & Wang, 2012), is a serious medical condition affecting 
approximately 350,000 – 900,000 Americans every year (Streiff et al., 2014). Deep vein 
thrombosis are blood clots that occur in deep veins in the body, often the lower extremity 
while PEs occur when a clot breaks loose and enters the arteries of the lungs (Office of 
the Surgeon General (U.S.); National Heart, Lung, and Blood Institute (U.S.), 2008). Of 
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the people who develop VTE, approximately 100,000 die due to sudden death, and 30% - 
50% with lower extremity DVT develop post thrombotic syndrome causing long term 
swelling, pain, discoloration, and ulcers in the affected extremity (Streiff et al., 2014). 
Furthermore, Streiff et al. (2014) report 10% -30% of people who survive the first 
occurrence will develop another VTE within five years.  
According to CMS, VTE is considered one of most preventable causes of death in 
hospitalized patients (Centers for Medicare & Medicaid Services, 2014b). In 2012, CMS 
added VTE to the hospital acquired conditions (HAC’s) reimbursement policies 
(Kohlbrenner, Whitelaw, & Cannaday, 2011). “Medicare, Medicaid, and private health 
plans alike are refusing to pay for complications that usually can be prevented by 
adopting the CMS HAC and the National Quality Forum never-event policies” 
(Kohlbrenner, Whitelaw, & Cannaday, 2011, p. 123). Hospital-acquired VTE care costs 
approximately $58, 627 per case (Kohlbrenner, Whitelaw, & Cannaday, 2011). 
Furthermore, Kohlbrunner, Whitelaw, and Cannaday (2011) reported in 2007 that health 
care facilities HAC costs accounted for 12.2% of the total liability costs. The Centers for 
Disease Control and Prevention (CDC) reported the United States spends $5to $8 billion 
per year on direct medical costs associated with VTE (CDC, 2011). The cost of VTE is 
expensive to the healthcare system and cannot be sustained.  
Despite many efforts to increase awareness of VTE in hospitalized patients, it still 
occurs. In the quest to reduce VTE, clinical information systems may provide support for 
clinicians to deliver consistent and reliable quality patient care. Hardwiring clinical 
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processes into electronic systems promotes safety and reduces the ability of staff to 
ignore or work around necessary measures that could save someone’s life and reduce the 
overall VTE cost to the healthcare system.  
American Academy of Orthopedic Surgery (AAOS) Guidelines 
The AAOS Preventing Venous Thromboembolic Disease in Patients Undergoing 
Elective Hip and Knee Arthroplasty Evidence-Based Guideline and Evidence Report 
(2011b) established clinical practice guidelines based on a systematic review of published 
studies on preventing venous thromboembolic disease in patients undergoing elective hip 
and knee arthroplasty. The AAOS report (2011b) provides a summary of the evidence 
rating methodology and description of the evidence strength to assist provider’s decision 
making in the prevention of VTE. The evidence ratings have been classified by the 
AAOS as strong, moderate, limited, inconclusive, and consensus. The following table 
provides a summary of the clinical practice guideline evidence rating recommendations 
on preventing VTE for elective hip and knee arthroplasty patients. 
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Table 1  
Recommendation Strengths, Descriptions and Clinical Implications According to the 
AAOS 
Evidence 
Rating 
Description of Evidence Strength Implication for Practice 
Strong Evidence is based on two or more “High” strength 
studies with consistent findings in support of 
recommending for or against the intervention. 
 
A Strong (positive) recommendation means that 
the benefits of the recommended approach clearly 
exceed the potential harm, and/or that the strength 
of the supporting evidence is high. 
A Strong (negative) recommendation means that 
the quality of the supporting evidence is high. A 
harms analysis on this recommendation was not 
performed. 
Practitioners should follow a 
Strong recommendation unless a 
clear and compelling rationale for 
an alternative approach is present. 
Moderate Evidence from two or more “Moderate” strength 
studies with consistent results, or evidence from a 
single “High” strength study recommending for or 
against the intervention. 
A Moderate recommendation means that the 
benefits exceed the potential harm (or that the 
potential harm exceeds the benefits in the case of a 
negative recommendation), but the 
quality/applicability of the supporting evidence is 
not as strong. 
Practitioners should generally 
follow a Moderate 
recommendation but remain alert 
to new information and be 
sensitive to patient preferences.  
Limited Evidence from two or more “Low” strength 
studies with consistent results, or evidence from a 
single Moderate strength study recommending for 
or against the intervention. 
 
A Limited recommendation means that the 
strength of the supporting evidence is 
unconvincing, or that well-conducted studies show 
little clear advantage to one approach over 
another.  
Practitioners should exercise 
clinical judgment when following 
a recommendation classified as 
Limited, and should be alert to 
emerging evidence that might 
negate the current findings. 
Patient preference should have a 
substantial influencing role.  
Inconclusive 
 
 
 
 
 
 
 
 
 
Evidence from a single low strength study or 
otherwise conflicting evidence that does not allow 
a recommendation to be made for or against the 
intervention.  
 
An Inconclusive recommendation means that 
there is a lack of compelling evidence that has 
resulted in an unclear balance between benefits 
and potential harm. 
 
Practitioners should feel little 
constraint in following a 
recommendation labeled as 
Inconclusive, exercise clinical 
judgment, and be alert for 
emerging evidence that clarifies 
or helps to determine the balance 
between benefits and potential 
harm.  
                            table continues 
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Evidence 
Rating 
Description of Evidence Implication for Practice 
  Patient preference should have a 
substantial influencing role. 
Consensus The supporting evidence is lacking and requires 
the work group to make a recommendation based 
on expert opinion by considering the known 
potential harm and benefits associated with the 
treatment. 
 
A Consensus recommendation means that expert 
opinion supports the guideline recommendation 
even though there is no available empirical 
evidence that meets the inclusion criteria for 
systematic review. 
Practitioners should be flexible in 
deciding whether to follow a 
recommendation classified as 
Consensus, although they may 
give it preference over 
alternatives. Patient preference 
should have a substantial role. 
Note. From “Preventing Venous Thromboembolic Disease in Patients Undergoing 
Elective Hip and Knee Arthroplasty,” by American Academy of Orthopedic Surgeons, 
2011, Evidence-Based Guideline and Evidence Report, p. 36.  
Within the AAOS report (2011b), recommendations of VTE management for 
pharmacological and mechanical prophylaxis discuss the three essentials. They are the 
use of pharmacological and mechanical prophylactic agents, the type of prophylactic 
strategy, and the duration of prophylaxis. The fifth recommendation of the AAOS report 
suggests the use of pharmacological agents and/or mechanical compression devices for 
the prevention of VTE disease in patients undergoing elective hip or knee arthroplasty, 
and who are not at elevated risk beyond that of surgery itself for VTE or bleeding. The 
grade of recommendation is moderate, which means that the benefits exceed the potential 
harm, but the strength of the supporting evidence is not as strong. The AAOS performed 
a network meta-analysis to assess which pharmacological prophylactic agent may be the 
most effective (AAOS, 2011b). The results of the analysis did not suggest that one type 
of pharmacological prophylaxis is superior over another. The AAOS (2011b) report 
further indicates that the current evidence is unclear about which prophylactic strategy is 
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optimal or suboptimal and is unable to provide recommendations for or against specific 
prophylactics in these patients. The grade of recommendation is inconclusive, which 
means there is lack of compelling evidence resulting in an unclear balance between 
benefits and potential harm (AAOS, 2011b). Table 1 provides a description of the 
evidence rating and implications of practice for an inconclusive recommendation.  
In the absence of reliable evidence about how long to employ these prophylactic 
strategies, it is the opinion of the work group that patients and physicians discuss the 
duration of prophylaxis (AAOS, 2011b). The grade of recommendation is consensus, 
which, means that expert opinion supports the guideline recommendation even though 
there is no available empirical evidence that meets the inclusion criteria of the guideline’s 
systematic review (AAOS, 2011b). Given the broad nature of the recommendations, the 
organization and orthopedic surgeons determined that there was important evidence to 
include aspirin, enoxaparin, and IPCDs in the electronic order set.  
American College of Chest Physicians (ACCP) Guidelines 
In 2012, the ACCP published Antithrombotic Therapy and Prevention of 
Thrombosis, 9th edition: CHEST Evidence-Based Clinical Practice Guidelines. The 
ACCP guidelines include the division of prevention into three major areas: medical 
patients, orthopedic surgery patients, and other surgical patients (Falck-Ytter et al., 
2012). For this project, the ACCP guidelines that focus on optimal prophylaxis to reduce 
postoperative VTE in orthopedic surgery patients will be discussed. Criteria suggested by 
the Grading of Recommendations Assessment, Development and Evaluation (GRADE) 
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working group were used to evaluate quality of evidence. Randomized control trials start 
as high-quality evidence and observational studies as low-quality evidence (Agency for 
Healthcare Research & Quality [AHRQ], 2014b).  
According to AHRQ (2014b) other factors that affect the rating of quality include 
the risk of bias; precision; consistency; directness of results; likelihood of publication 
bias; and presence of very large effects. The ACCP modification of the GRADE system 
differs only in that the quality of a body of evidence can be high (A), moderate (B), or 
low (C) (AHRQ, 2014b). “The formulation of recommendations considered the balance 
between the desirable and undesirable consequences of an intervention; the quality of the 
evidence; the variability in patient values and preferences; and, on occasion, resource use 
issues” (AHRQ, 2014b, para. 37).  
When desirable effects were much greater than undesirable effects, the 
recommendations were graded as strong. Strong recommendations were labeled 1 and 
worded as “The expert panel recommends” (AHRQ, 2014b). “Recommendations were 
graded as weak when desirable effects were not clearly greater or less great than 
undesirable effects” (AHRQ, 2014b, para. 37). Weak recommendations were labeled as 2 
and worded as “The expert panel suggests” (AHRQ, 2014b). The rating of the quality of 
evidence- high, A; moderate, B; or low, C is provided with the strength of each 
recommendation (AHRQ, 2014b). Table 2 provides a summary of the ACCP rating 
scheme for the strength of the recommendations on the prevention of VTE in orthopedic 
surgery patients. 
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Table 2  
Strength of the Recommendations Grading System According to the ACCP 
Grade of 
Recommendation* 
Benefit vs. 
Risk and 
Burdens 
Methodologic Quality of 
Supporting Evidence 
Implications 
Strong 
recommendation, high-
quality evidence,  
Grade 1A 
Benefits 
clearly 
outweigh 
risk and 
burdens or 
vice versa. 
Consistent evidence from 
randomized controlled 
trials (RCTs) without 
important limitations or 
exceptionally strong 
evidence from 
observational studies. 
Recommendation can apply to 
most patients in most 
circumstances. Further research is 
very unlikely to change 
confidence in the estimate of 
effect. 
Strong 
recommendation, 
moderate-quality 
evidence,  
Grade 1B 
Benefits 
clearly 
outweigh 
risk and 
burdens or 
vice versa. 
Evidence from RCTs with 
important limitations 
(inconsistent results, 
methodologic flaws, 
indirect or imprecise), or 
very strong evidence from 
observational studies. 
Recommendation can apply to 
most patients in most 
circumstances. Higher quality 
research may well have an 
important impact on confidence in 
the estimate of effect and may 
change the estimate. 
Strong 
recommendation, low- 
or very-low-quality 
evidence,  
Grade 1C 
Benefits 
clearly 
outweigh 
risk and 
burdens or 
vice versa. 
Evidence for at least one 
critical outcome from 
observational studies, case 
series, or from RCTs with 
serious flaws or indirect 
evidence. 
Recommendation can apply to 
most patients in many 
circumstances. Higher-quality 
research is likely to have an 
important impact on confidence in 
the estimate of effect and may 
well change the estimate. 
Weak 
recommendation, high-
quality evidence, 
Grade 2A 
Benefits 
closely 
balanced 
with risks 
and burden. 
Consistent evidence from 
RCTs without important 
limitations or exceptionally 
strong evidence from 
observational studies. 
The best action may differ 
depending on circumstances or 
patient or society values. Further 
research is very unlikely to 
change confidence in the estimate 
of effect. 
Weak 
recommendation, 
moderate-quality 
evidence,  
Grade 2B 
Benefits 
closely 
balanced 
with risks 
and burden. 
Evidence from RCTs with 
important limitations 
(inconsistent results, 
methodologic flaws, 
indirect or imprecise) or 
very strong evidence from 
observational studies  
Best action may differ depending 
on circumstances or patient or 
society values. Higher-quality 
research may well have an 
important impact on confidence in 
the estimate of effect and may 
change the estimate. 
                          table continues 
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Grade of 
Recommendation* 
Benefit vs. Risk 
and Burdens 
Methodologic Quality 
of Supporting Evidence 
Implications 
Weak 
recommendation, low- 
or very-low-quality 
evidence,  
Grade 2C 
Uncertainty in the 
estimates of benefits, 
risks, and burden; 
benefits, risk, and 
burden may be 
closely balanced. 
Evidence for at least one 
critical outcome from 
observational studies, 
case series, or RCTs, 
with serious flaws or 
indirect evidence  
Other alternatives may be 
equally reasonable. Higher-
quality research is likely to 
have an important impact on 
confidence in the estimate of 
effect and may well change 
the estimate. 
 
Note. From “Prevention of VTE in Orthopedic Surgery Patients: Antithrombotic Therapy 
and Prevention of Thrombosis, 9th ed: Evidence-Based Clinical Practice Guidelines,” by 
American College of Chest Physicians, 2012, AHRQ National Guideline Clearinghouse, 
para. 42. 
The ACCP Guidelines for Prevention of VTE in Orthopedic Surgery Patients 
(2012) are more prescriptive in their recommendations for pharmacological and 
mechanical prophylaxis than the AAOS 2011 VTE Prevention Guidelines. In patients 
undergoing total hip or total knee arthroplasty, the ACCP (2012) recommends the use of 
low-molecular weight heparin such as enoxaparin and aspirin (Grade 1B) or an 
intermittent pneumatic compression device (IPCD Grade 1C). Low molecular-weight 
heparin such as enoxaparin is recommended and preferred to other pharmacological 
agents (Grade 2B/2C). During the hospital stay, IPCD’s are recommended in addition to 
pharmacological prophylaxis (Grade 2C Falck-Ytter, et al., 2012). Pharmacological 
prophylaxis should be extended for up to 35 days after discharge from the hospital (Grade 
2B Falck-Ytter, et al., 2012). Intermittent pneumatic compression devices or no 
prophylaxis is suggested for patients with increased bleeding risk (Falck-Ytter, et al., 
2012).   
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 Upon review of the ACCP 2012 VTE recommendations specific to orthopedic 
surgery patients, the organization and orthopedic surgeons were able to finalize how each 
prophylactic agent would be used following surgery. Aspirin was recommended for 
patients classified at routine risk, while enoxaparin was recommended for patients 
classified at high risk of developing VTE. IPCDs would be applied to all patients 
postoperatively before leaving the operating room. The organization and orthopedic 
surgeons reached consensus to include aspirin, enoxaparin, and IPCD orders in the 
postoperative electronic VTE order set.  
Technology/CPOE 
The landmark report To Err is Human published in 1999 by the Institute of 
Medicine (IOM), has prompted hospitals to closely examine care delivery models and 
implement strategies to reduce medical errors and improve patient safety. The IOM 
reported that preventable adverse events are a leading cause of death in United States 
hospitals, accounting for between 44,000 – 98,000 lives lost yearly due to medical errors 
(Kohn, Corrigan, & Donaldson, 2000). Furthermore, medication errors are cited as one of 
the most common errors in hospitals (Kohn, Corrigan, & Donaldson, 2000). One of the 
key strategies identified to improve medication safety is computerized provider order 
entry (CPOE). Electronic order entry benefits include not having to decipher illegible 
handwriting, clinical checking decisions made by providers at the beginning of the 
medication cycle, and decreased turnaround time from order placement to actual 
medication administration 
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It is no secret to healthcare that hospitals have been slow to adopt health 
information technology (HIT), specifically electronic health records (EHRs). One of the 
major factors of slow adoption of this technology is related to the cost of implementation 
and maintenance of the system while trying to maintain a positive financial performance 
(Encinosa & Bae, 2013). In the State of the Union Address in 2004, President Bush 
presented a HIT plan offering Americans EHRs within 10 years that would improve 
quality, decrease cost, and reduce preventable errors (The White House, 2004). In 2009 
to stimulate the economy, President Obama proposed and signed a bill passing the 
American Recovery and Reinvestment Act (ARRA). Part of the ARRA initiative is to 
modernize healthcare by offering financial incentives to hospitals if they are using a 
certified EHR in a meaningful way as defined in the different stages of Meaningful Use 
(MU) criteria (The White House, 2009). 
The patient safety organization Leapfrog (2015) recommends the use of 
computerized provider order entry (CPOE) to integrate guidance for the physician into 
the flow of patient care, via standard order sets. As part of a patient safety quality 
improvement initiative, organizations such as Johns Hopkins have developed 
multidisciplinary VTE prevention teams using technology to design evidence-based 
strategies to prevent VTE (Streiff et al., 2014). The Johns Hopkins team determined that 
paper-based order sets were difficult to use and developed computer-based VTE smart 
order sets (Streiff et al, 2014). The VTE smart order sets were inserted into all admission 
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and transfer order sets for all medical and surgical patients. Streiff et al. (2014) reported 
VTE prophylaxis increased to 85% with the addition of smart order sets.  
Maynard and Stein (2010) also recommend embedding electronic VTE order sets 
into admission, transfer, and perioperative electronic order sets. The implementation of 
HIT, such as smart order sets can lead to efficient clinician workflow and improved 
quality patient outcomes. Providing appropriate protocol guidance within the electronic 
order set that enables efficient clinical decision making may lead to a reduction in 
orthopedic VTE outcomes. 
Conceptual Framework 
An appropriate model to explore the problem of VTE in the postoperative 
orthopedic THA patient population was the Accountable Care Organization (ACO) 
model. The triple aims of the ACO model underscores reducing cost, improving quality, 
and enhancing patient experience (McClellan, McKethan, Lewis, Roski, & Fisher, 2010). 
Accountable Care Organizations are groups of doctors, hospitals, and other health care 
providers, who come together to provide more coordinated, high quality care to Medicare 
patients at lower cost (McClellan et al., 2010).  
A core principle of the ACO model is the implementation of a robust quality 
measurement strategy (McClellan et al., 2010). According to the AAOS (2011a), “The 
ACO model is the first attempt to link quality and patient experience to financial rewards 
when providers meet quality and cost containment benchmarks” (p. 8). Furthermore, 
AAOS (2011a) recommends the need for technology platforms and systems that will 
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enable data gathering, data integration, and public reporting of quality and cost outcomes 
will be required for ACOs to be successful. Developing a robust quality measurement 
strategy specifically related to VTE in the orthopedic population may instill public 
confidence that cost savings are directly linked to evidence-based nursing practice and 
care improvements.  
An essential goal of an ACO is to ensure patients receive coordinated care at the 
right time while avoiding duplicative services and medical errors. As an ACO begins to 
deliver high quality care at less cost, the ACO can share in the savings realized in the 
Medicare program (CMS, 2015a). ACO models offer nurses the opportunity to act as care 
coordinators, communicators, quality improvement managers, and providers of advanced 
levels of care (Nursing Alliance for Quality Care, n.d.). Within the care coordinator 
model, nurse case managers have the opportunity the implement an evidence-based 
screening tool to identify orthopedic patients at increased risk for VTE and develop a 
plan of care to manage this risk prior to hospital admission, during the acute 
hospitalization, and the postacute care phase. Well-coordinated early identification and 
intervention by nurses may result in improved outcomes and overall VTE management 
for the postoperative orthopedic population.  
Summary 
 Venous thromboembolism remains an important and serious complication for 
patients undergoing joint replacement surgery. Even though there are practice guidelines 
from the AAOS and ACCP on the prevention of VTE for orthopedic patients, the 
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guidelines are cumbersome, very lengthy and not aligned. Lack of consistent 
recommendations can cause confusion for providers over which pharmacological agent is 
most effective in preventing postoperative thrombosis. Practice guidelines support that a 
multimodal approach is necessary to decrease the risk of developing VTE. After review 
of the literature, the organization’s orthopedic surgeons agreed to standardize VTE 
prophylaxis in the electronic order set. Aspirin was the agent of choice for patients at 
standard risk and enoxaparin was the agent of choice for patients at higher risk of 
developing VTE after hip replacement surgery. Intermittent pneumatic compression 
devices were also part of standard VTE prophylaxis therapy and were to be ordered for 
all postoperative hip replacement patients. Implementation of the evidence-based 
electronic order set increased the provider’s adherence to ordering standard prophylactic 
treatment and decreased VTE orthopedic outcomes. The next section will discuss the 
project design and methods.          
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Section 3: Methodology 
Introduction 
 Kettner, Moroney and Martin (2013) stated “the purpose of the program design 
phase is to put together that service or combination of services that appears to have the 
best possible chance of achieving the program’s objectives” (p. 19). Obtaining input from 
key stakeholders on the design of this program was critical to its success. The hospital 
organization study site had been an outlier in orthopedic VTE outcomes with 
performance in the bottom 10th percentile nationally. The purpose of this project was to 
assess the difference of orthopedic VTE occurrences in the postoperative THA patient 
before and after implementation of the electronic VTE order set. There were two 
objectives for the project (a) to evaluate if technology influences the adherence to 
ordering of mechanical prophylaxis in the THA patient (b) to evaluate if technology 
influences the adherence to ordering pharmacological prophylaxis in the THA patient. In 
this section, I will discuss the project design, population and sampling, data collection, 
data collection tool, protection of human subjects, data analysis, and project evaluation 
plan.   
Project Design and/or Methods 
All primary total hip arthroplasty cases between the preelectronic order set 
implementation period of January 1, 2014-June 30, 2014 and the postelectronic order set 
implementation period of January 1, 2015-June 30, 2015 was provided by Stryker. 
Stryker is a contracted vendor that specializes in collecting and extracting important 
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hospital metrics into an outcomes dashboard. Stryker provided the hip arthroplasty cases 
to the hospital organization’s chief medical information office (CMIO). The CMIO 
obtained information from the embedded analytics clinical information system. I 
calculated a comparison of the percent of adherence to pharmacological and mechanical 
prophylaxis before and after implementation of the electronic order set to evaluate if 
technology was affecting consistent ordering of prophylaxis treatment. The VTE 
occurrence rate was reported before and after implementation of the electronic order set. 
Stryker provided VTE occurrences for the pre- and postelectronic order set 
implementation period to assess if technology was positively or negatively impacting 
VTE outcomes.   
Population and Sampling 
 I collected the target data from discharged patients that underwent a primary THA 
between January 1, 2014-June 30, 2014 and January 1, 2015-June 30, 2015. The project’s 
inclusion criterion was that the patient underwent a primary total hip replacement 
procedure. Hip revision and hip fracture procedures were excluded from the project. 
Total hip replacement patients had a diagnosis of osteoarthritis or degenerative joint 
disease and had to meet the criteria for medical necessity. The participants ranged in age 
from 40 to 90 and included all types of insurance. The THA payer mix consisted of 40% 
commercial, 30% managed Medicare, 25% Medicare, 2% Medicaid, and 3% other. 
Approximately 400 THA procedures are performed within a 6-month period at the 
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facility. I included the electronic medical record for every patient who underwent a 
primary THA during the two defined time periods above.     
Data Collection 
 The data provided by Stryker contained every primary THA procedure performed 
between January 1, 2014-June 30, 2014 and January 1, 2015-June 30, 2015. The data 
parameters comprised the participants’ account number, admission date, discharge date, 
procedure type, VTE complications during admission, and readmissions within 30 days 
of discharge for VTE. The procedure data were delivered to the CMIO via an encrypted 
Excel file that required a password to access. The CMIO used patient account numbers 
provided by Stryker to query the embedded analytics database from the hospital 
organization’s clinical information system. The CMIO used structured query language to 
pull cases in which VTE prophylaxis, mechanical, and/or pharmacological prophylaxis 
was ordered. The data were then compiled in an Excel spread sheet and sent to me. All 
participants were completely deidentified and assigned a patient number by the CMIO. 
From there, I analyzed the differences in ordering VTE prophylaxis, mechanical and 
pharmacological prophylaxis, and VTE outcomes before and after the implementation of 
the electronic order set.  
Instruments 
 Data collection tool. I developed one of the data collection tools in Excel for the 
project (Appendix A) myself. The tool contained headings to capture the variables 
participant numbers assigned, admit date, discharge date, procedure type, VTE 
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complication during admission, VTE readmit within 30 days, VTE prophylaxis ordered, 
mechanical prophylaxis ordered, and pharmacological prophylaxis ordered. I developed 
the tool to have VTE complication during admission, VTE readmit within 30 days, and 
prophylaxis ordering have a corresponding yes or no entered to examine the difference in 
the percentages of ordering of the order set and the VTE outcomes before and after 
implementation of the electronic order set.  
Protection of Human Subjects 
 I obtained approval from hospital administration, the chief medical officer, the 
chief of orthopedic surgery, and Walden University’s Institutional Review Board (IRB) 
prior to beginning the project. The IRB approval number for this study is 03-30-17-
0183526. I also completed The National Institutes of Health web-based training course 
“Protecting Human Research Participants” on February 16, 2014 (Certification Number 
1404756). The key stakeholders were made aware of the purposes of the project and were 
given the opportunity to ask questions. I stored data collected for the project in a secure, 
encrypted, password protected file located on my computer hard drive. The computer was 
kept in a locked office that was accessible only to me. To comply with Health Insurance 
Portability and Accountability Act, all patient specific information was deidentified. In 
accordance with the organizational policy, protection of patient information was 
maintained at all times. 
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Data Analysis 
 I used descriptive statistics to analyze the data collected from the project. 
Descriptive statistics are numbers that are used to summarize and describe data (Grove, 
Burns, & Gray, 2013). The differences in the ordering of VTE prophylaxis, mechanical 
and pharmacological prophylaxis, and VTE outcomes both before and after 
implementation of the order set were analyzed and compared. The differences between 
the pre-and postorder set implementation results were displayed as a percentage change.  
 There were four project questions. The first project question was: What is the 
difference in the ordering of VTE prophylaxis before and after implementation of the 
electronic order set? I used descriptive statistics to determine and compare the percentage 
of orders for VTE prophylaxis and the percentage of orders with no VTE prophylaxis. 
The results were completed both before and after implementation of the electronic order 
set. A comparison of the change in percentage of VTE ordering adherence both before 
and after implementation of the order set were examined to determine if the order set 
promoted ordering adherence.  
The second question was: What is the difference in the ordering of mechanical 
prophylaxis before and after implementation of the electronic order set? I used descriptive 
statistics to determine and compare the percentage of orders for mechanical prophylaxis 
only and the percentage of orders with no mechanical prophylaxis. A comparison of the 
change in percentage of mechanical prophylaxis ordering adherence both before and after 
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implementation of the electronic order set were examined to determine if the order set 
promoted mechanical prophylaxis ordering adherence.  
The third question was: What is the difference in the ordering of pharmacological 
prophylaxis before and after implementation of the electronic order set? I used descriptive 
statistics to determine and compare the percentage of orders for pharmacological 
prophylaxis only and the percentage of orders with no pharmacological prophylaxis. A 
comparison of the change in percentage of pharmacological prophylaxis ordering 
adherence both before and after implementation of the electronic order set were examined 
to determine if the order set promotes pharmacological prophylaxis ordering adherence. I 
also completed another analysis with descriptive statistics to assess the percentage of 
orders for both mechanical and pharmacological prophylaxis ordering adherence before 
and after implementation of the electronic order set. This analysis indicated whether 
implementation of the order set resulted in VTE prophylaxis ordering for both agents.   
The fourth question was: What is the difference in orthopedic VTE occurrences 
before and after implementation of the electronic order set? I calculated the percentage of 
participants that developed VTE either during hospital admission or were readmitted 
within 30 days of discharge with VTE using descriptive statistics to determine the 
percentage of VTE outcomes. A comparison of VTE outcomes both before and after 
implementation of the order set were completed to evaluate if technology influenced VTE 
ordering adherence and reduced VTE occurrences in THA patients.  
 
56 
   
Project Evaluation Plan 
 The plan-do-check-act (PDCA) or Deming cycle was an appropriate model to 
evaluate the project. The PDCA cycle is a sequence of steps to obtain valuable learning 
and knowledge for continuous improvement of a process or system (Taylor et al, 2014). 
The PDCA cycle is used within the hospital organization to continuously and objectively 
measure, monitor, evaluate, identify, and pursue opportunities to improve the outcomes 
of patient care, service delivery and minimize the chances of adverse outcomes and 
events. The organization’s quality department has been using this model of evaluation for 
over 25 years because the steps are easy to follow and it represents a continual process to 
explore improvement. The PDCA model provided an opportunity for me to evaluate 
whether a standardized electronic VTE order set improved or worsened the adherence to 
ordering mechanical and pharmacological prophylaxis and orthopedic VTE outcomes. 
Analyzing the test of change informed me that sustainable improvement was possible and 
the process did not require modification. Figure 1 provides a visual representation of the 
PDCA Deming quality improvement cycle. 
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Figure 1. Illustration showing Deming’s cycle plan do check act. From “Systematic 
Review of the Application of the Plan-Do-Study-Act Method to Improve Quality in 
Healthcare,” by Taylor, McNichols, Nicolay, Daizi, Bell, and Reed, 2014, BMJ Quality 
and Safety 23(4), p. 292. Reprinted with permission. 
Summary 
 In this project, I explored if technology influenced the adherence to ordering 
mechanical and pharmacological prophylaxis in the postoperative THA patient. I 
conducted an analysis using descriptive statistics to gather data on the adherence to 
ordering prophylaxis and VTE outcomes. The data were analyzed to determine the 
difference in ordering VTE prophylaxis after the order was implemented. A plan for the 
protection of human subjects was maintained throughout the project. The PDCA model 
was used to evaluate the project plan and the difference of orthopedic VTE occurrences 
before and after implementation of the electronic order set. The next section will discuss 
the findings and implications from the project. 
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Section 4: Findings, Discussion, and Implications 
Introduction 
 The purpose of the DNP project was to assess the difference of orthopedic VTE 
occurrences in the postoperative THA patient before and after the implementation of the 
electronic VTE order set. The ACSNSQIP 2014 Semiannual Report for the period of 
January 2014 - March 2015 reported 10 VTE events in 546 orthopedic cases at the study 
site. Based on the orthopedic VTE outcomes data, the hospital organization study site has 
been classed as an outlier performing in the bottom 10th percentile when compared to 
other organizations. I conducted this quality improvement project initiative at a regional 
tertiary care facility comprised of 450 acute care beds. The organization has a large total 
joint replacement program with almost 3,000 arthroplasty surgeries performed annually.   
THA cases and VTE complications were provided for this project by Stryker for 
the preelectronic order set period of January 1, 2014-June 30, 2014 and the postelectronic 
order set implementation period of January 1, 2015-June 30, 2015. Using the THA cases 
from Stryker, the hospital organization’s CMIO queried the EHRs to determine if VTE 
prophylaxis and mechanical and pharmacological prophylaxis ordering adherence was 
followed before and after implementation of the electronic order set. The data were 
compiled in an Excel spreadsheet and sent to me for analysis. I analyzed the differences 
in ordering of VTE prophylaxis, mechanical and pharmacological prophylaxis, and VTE 
outcomes both before and after implementation of the order set and compared as a 
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percentage of change. In this section, I will discuss the project findings, practice 
implications, project outcomes, and project strengths and limitations.  
Summary and Evaluation of Findings 
 With this DNP project, I aimed to evaluate the difference of orthopedic VTE 
occurrences in the postoperative THA patient before and after the implementation of the 
electronic order set. I had two objectives for this DNP project (a) to evaluate if 
technology influenced the adherence to ordering mechanical prophylaxis in the THA 
patient and (b) to evaluate if technology influenced the adherence to ordering 
pharmacological prophylaxis in the THA patient.  
Given the objectives of the project, I developed the following four questions to 
guide the study:   
1. “What is the difference in the ordering of VTE prophylaxis before and after 
implementation of the electronic order set”?  
2. “What is the difference in ordering of mechanical prophylaxis before and after 
implementation of the electronic order set”?  
3. “What is the difference in the ordering of pharmacological prophylaxis before 
and after implementation of the electronic order set”?  
4. “What is the difference in orthopedic VTE occurrences before and after 
implementation of the electronic order set”?  
In the following subsections, I will discuss the findings that resulted from my analysis.  
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Project Question 1 
There were a total of 325 primary THA participants included in the preelectronic 
order set group for January 1, 2014-June 30, 2014 time period. Of the participants, 120 or 
36.9% were men and 205 or 63.1% were women. The average age of men and women 
were 64 and 67 years, respectively. VTE prophylaxis was ordered for 281 of 325 or 
86.5% of the participants. Forty-four of 325 or 13.5% of the participants did not have 
VTE prophylaxis orders consistent with either aspirin or enoxaparin.    
There were a total of 406 primary THA participants included in the postelectronic 
order set group for January 1, 2015-June 30, 2015 time period. Of the participants, 186 or 
46% were men and 220 or 54% were women. The average age of men and women were 
62 and 67 years, respectively. VTE prophylaxis was ordered for 362 of 406 or 89.2% of 
the participants. Forty-four of 406 or 10.8% of the participants did not have VTE 
prophylaxis orders consistent with either aspirin or enoxaparin.  
Prior to the electronic order set implementation, the ordering of VTE prophylaxis 
was 86.5%. The postelectronic ordering of VTE prophylaxis increased to 89.2%. The 
difference between the pre- and postelectronic order set represents an increase of 2.7%.  
Project Question 2 
 Three hundred and twenty-five of 325 or 100% of primary THA participants had 
orders for mechanical prophylaxis with IPCDs prior to the electronic order set 
implementation. Four hundred and six of 406 or 100% of primary THA participants had 
orders for mechanical prophylaxis with IPCDs after the electronic order set was 
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implemented. Ordering adherence for mechanical prophylaxis with IPCDs has remained 
consistent with performance at 100%.  
Project Question 3 
 Prior to the implementation of the electronic order set, 281 of 325 or 86.5% of 
primary THA participants had pharmacological VTE prophylaxis orders. Two hundred 
and eight of 325 or 64% of participants had aspirin orders and 73 of 325 or 22% had 
orders for enoxaparin. Forty-four of 325 or 13.5% of participants had orders for other 
pharmacological agents such as warfarin, dabigatran, and apixaban. These agents are not 
considered part of the agreed upon VTE prophylactic protocol by the orthopedic 
surgeons, and I placed them in the nonadherent category.  
 After the electronic order set implementation, 362 of 406 or 89.2% of primary 
THA participants had pharmacological VTE prophylaxis orders. Two hundred and 
seventy-seven of 406 or 68% of the participants had aspirin orders and 85 of 406 or 
20.9% had orders for enoxaparin. Forty-four of 406 or 10.8% of participants had orders 
for warfarin, dabigatran, rivaroxaban, and apixaban. These agents are not considered part 
of the agreed upon VTE prophylactic protocol by the orthopedic surgeons and were not 
included in the standardized electronic order set. I placed the ordering of these agents in 
the nonadherent category.  
 For the preelectronic order set period, pharmacological VTE prophylaxis ordering 
adherence was 86.5%, compared to the postelectronic order set period, which was 89.2%. 
The difference observed between the two periods represents an increase of 2.7% in the 
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ordering of pharmacological prophylaxis. The percentage of nonadherence to ordering 
VTE pharmacological prophylaxis was 13.5% in the preelectronic order set period 
compared to 10.8% in the postelectronic order set period. The difference observed 
between the two periods is a reduction of 2.7%. The percentage of orders for both 
mechanical and pharmacological prophylaxis ordering adherence prior to the electronic 
order set was 281 of 325 or 86.5%, compared to the postelectronic order set period, which 
was 362 of 406 or 89.2%. The difference observed between the two periods represents an 
increase of 2.7% in the ordering of both mechanical and pharmacological prophylaxis. 
The increase is attributed to the ordering of pharmacological agents because the ordering 
of mechanical prophylaxis was 100%, both before and after implementation of the 
electronic order set.  
Project Question 4 
 Before implementation of the electronic order set, 10 of 325 or 3.08% of primary 
THA participants developed a postoperative VTE. Two of 325 or .62% of VTEs occurred 
during hospital admission and 8 of 325 or 2.46% were readmitted within 30 days of 
hospital discharge. After implementation of the electronic order set, 3 of 406 or .74% of 
primary THA participants developed a postoperative VTE. One of 406 or .25% of VTEs 
occurred during hospital admission and 2 or .49% was readmitted within 30 days of 
hospital discharge.  
 For the preelectronic order set period, 3.08% of participants developed a VTE as 
compared to .74% for the postelectronic order set period. The difference I observed 
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between the two-time periods represents a decrease in VTE outcomes of 2.34%. For the 
preelectronic order set period, 2 of 325 or .62% of participants developed VTE during the 
postoperative hospital admission as compared to 1 of 406 or .25% for the postelectronic 
order set period. The difference observed represents a decrease of postoperative hospital 
admission VTE by .37%. For the preelectronic order set period, 8 of 325 or 2.46% of 
participants developed VTE within 30 days of hospital discharge as compared to 2 of 406 
or .49% for the postelectronic order set period. The difference observed represents a 
decrease in the VTE 30-day readmission rate by 1.97%.  
Discussion of Findings in the Context of the Literature 
 I had two objectives for this quality improvement initiative. My first objective was 
to evaluate if technology influenced the adherence to ordering of mechanical VTE 
prophylaxis in the THA patient. The findings revealed that mechanical prophylaxis was 
ordered 100% of the time both before and after implementation of the electronic order set. 
The results suggested that technology did not have a negative impact on mechanical 
prophylaxis ordering adherence, and performance of 100% was sustained with electronic 
order entry. While paper-based order sets were difficult for providers to use, the practice 
of ordering mechanical prophylaxis was hardwired into provider practice. With the 
practice change of electronic order entry, the ordering of mechanical prophylaxis was 
easily adopted and transferred with electronic order entry.  
 According to Cooley, May, Alwan and Sue (2012), studies have shown that when 
end users are involved in the design of order set content there is a greater likelihood of 
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successful CPOE implementation. Orthopedic subject matter experts were heavily 
involved in the content development and format of the electronic order set. Their 
involvement may have contributed to sustaining exemplary results with new technology 
rather than observing a decline in ordering adherence. Developing standard VTE order 
sets and protocols assures the patient receives the agreed upon standard (Maynard & 
Stein, 2010). By standardizing with electronic order sets, the need to remember all 
aspects of care for the clinician is reduced.  
 My second objective was to evaluate if technology influenced the adherence to 
ordering pharmacological VTE prophylaxis in the THA patient. The findings revealed 
that there was an increase of 2.7% in ordering the pharmacological prophylaxis protocol 
from 86.5% to 89.2%. Nonadherence to ordering the pharmacological prophylaxis 
protocol decreased by 2.7% from 13.5% to 10.8%. Based on these findings, the electronic 
order set has positively influenced pharmacological ordering adherence and decreased 
ordering outside of the protocol. Patients are more likely to be prescribed VTE 
prophylaxis with a standardized order set (O’Connor, Adhikari, DeCaire, & Friedrich, 
2009).  
The pre- and postelectronic order set time periods that I analyzed demonstrated 
that orthopedic VTE outcomes decreased by 2.34% from 10 to three occurrences in the 
postoperative THA patient. When integrated with technology, standardized care processes 
provide for more reliable consistent care delivery and better patient outcomes 
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(McCartney, 2014). Well-designed evidence-based order sets can transform clinical 
processes and clinician behavior.  
The conceptual framework that I used for the DNP quality improvement project 
was the Accountable Care Organization (ACO) model. The triple aims of the ACO model 
underscores reducing cost, improving quality, and enhancing patient experience 
(McClellan, McKethan, Lewis, Roski, & Fisher, 2010). A core principle of the ACO 
model is the implementation of a robust quality measurement strategy (McClellan et al., 
2010). The model supported the work of the project by leveraging technology to query 
the clinical information system to evaluate VTE prophylaxis ordering adherence and 
orthopedic VTE outcomes. Prophylaxis ordering adherence information and misses can 
be shared with providers in a timely manner to improve quality care, prevent VTE 
outcomes, and improve patient experience. 
Implications 
Policy 
In 2008, the Surgeon General’s call to action to prevent VTE declared that at least 
350,000, and as many as 600,000 Americans develop VTE, and approximately 100,000 
deaths are thought to be related to VTE (Office of the Surgeon General (U.S.); National 
Heart, Lung, and Blood Institute (U.S.), 2008). The Centers for Medicare and Medicaid 
Services (CMS, 2014a) and the Agency for Healthcare Research and Quality (AHRQ, 
2014a) have reported that VTE is the most common preventable cause of hospital death. 
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Postoperative VTE is a common complication of surgical procedures that can lead to 
increased length of stay, excess mortality, and increased cost (Johnson & Riley, 2012).  
The incidence of confirmed hospital acquired VTE ranges from 40% -60% among 
orthopedic surgery patients (Johnson & Riley, 2012). Despite this, not all patients receive 
an appropriate VTE prophylaxis due to a disproportionate fear of bleeding complications 
(Cionac Florescu et al., 2013). Given the staggering statistics of postoperative VTE in 
orthopedic surgery patients and the organization’s prior poor performance, the decision to 
standardize care with the implementation of an electronic order set has demonstrated a 
decrease in postoperative orthopedic VTE outcomes for total hip arthroplasty patients.  
Practice 
The history of the literature demonstrates that chemical thromboembolism 
prophylaxis has been controversial in the prevention of postoperative VTE in orthopedic 
surgery patients (AAOS, 2011b). The PEP (2000) study and ATC (2002) meta-analyses 
provided strong evidence that aspirin reduces the incidence of VTE after major 
orthopedic surgery. Despite these results, the AAOS and ACCP guidelines were not 
consistent in their recommendations of aspirin to prevent postoperative VTE in THA 
patients.   
The latest VTE prevention guidelines were published by AAOS in 2011 and 
ACCP in 2012. As evidence is acquired, it is important to evaluate the level of evidence 
and quality (American Nurses Association, 2015). The American Nurses Association 
(2015) notes there are numerous scales for levels of evidence ranging from three to seven 
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levels. The definitions of levels of evidence have not been standardized (American 
Nurses Association, 2015). Clinical practice guidelines published by two different 
nationally recognized organizations that lack standardized levels of evidence can be 
problematic for clinicians to fully appraise the evidence to prevent VTE disease in the 
postoperative orthopedic population. The clinical practice guidelines published by the 
AAOS and ACCP employ different levels of evidence that are not aligned in a 
standardized approach. Clinicians are challenged by inconsistencies in the literature, 
which may cause confusion when attempting to adopt evidence-based practices. After 
thorough review of the evidence, the organization determined aspirin was appropriate 
prophylaxis for postoperative orthopedic arthroplasty procedures and provider ordering 
adherence has increased with the electronic order set.    
Research 
 The results of the DNP quality improvement initiative demonstrated that 
technology positively influenced VTE prophylaxis ordering adherence and reduced 
postoperative orthopedic VTE outcomes. Reducing postoperative and 30 day 
readmissions for VTE will have positive financial results for the hospital. According to 
Kohlbrenner, Whitelaw, and Cannaday (2011) hospital-acquired VTE care costs 
approximately $58,627 per case. Based on the results of the quality improvement 
initiative, there were seven less VTE’s in the postelectronic order set group. This 
accounts for a total of $410,704 in savings for the organization. Venous 
thromboembolism is a preventable condition that requires additional research and 
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analysis by the organization to ensure all patients receive appropriate prophylaxis. 
Additional measures will be considered with effective system design and electronic 
alerting mechanisms at the right time of care processes, delivery, and evaluation, which 
can reduce and virtually eliminate a near miss for VTE prophylaxis (Streiff et al., 2014).         
Social Change 
 The DNP quality improvement project impacted social change by decreasing the 
number of patients with postoperative VTE following THA surgery. Through the 
development and implementation of the project, I demonstrated the ability to appraise and 
critique the evidence in the context of the orthopedic patient. The orthopedic surgeons 
were very interested to learn since implementing the electronic order set that ordering 
adherence to VTE prophylaxis had increased and VTE outcomes decreased. The 
prevention and management of VTE continues to pose patient safety issues in most U.S. 
hospitals (Duff, Walker, & Omari, 2011). The results of the project have had a positive 
influence on the orthopedic surgeons because they are no longer willing to accept VTE as 
a normal complication and want to provide the safest care possible. The orthopedic 
surgeons have asked for their specific VTE prophylaxis ordering adherence reports and 
are committed to performing case reviews when the protocol is not followed. The project 
also encouraged nurses to identify when the protocol is not used and place a phone call to 
the provider to discuss and obtain appropriate orders. Future social change may also 
explore launching an orthopedic VTE prophylaxis campaign for patients and families to 
educate them on preventing a serious post-operative complication.       
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Project Strengths and Limitations 
Strengths 
 One of the strengths of the quality improvement project is the sample size that 
was evaluated for the pre and post order set time periods. According to Grove, Burns, and 
Gray (2013) the sampling component is an important part of the project process that 
needs to be well thought out and described clearly. Specific inclusion and exclusion 
criteria were defined for the pre and postelectronic order set six month time periods that 
were evaluated. A total of 325 THA cases were examined for the preelectronic order set 
period of January 1 2014 through June 30 2014 and 406 THA cases were examined for 
the postelectronic order set period of January 1 2015 through June 30 2015.  
A second strength of the quality improvement project was that it evaluated 
provider ordering adherence to VTE prophylaxis, mechanical, and pharmacological 
prophylaxis. Prior to this project, this type of data was not measured by the organization 
and shared with the providers. The orthopedic providers did not have knowledge of their 
baseline VTE prophylaxis ordering adherence. In the absence of a baseline compliance 
result, the orthopedic providers were unsure if the electronic ordering pathway would 
increase or decrease their level of compliance and improve VTE outcomes. The results of 
the DNP project proved that 100% ordering adherence was sustained for mechanical 
prophylaxis, chemical prophylaxis ordering increased, and VTE outcomes were reduced 
with implementation of the electronic order set.  
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Limitations 
 One of the limitations of the quality improvement project was that another six 
month period was not evaluated after the order set was implemented to assess if ordering 
adherence continues to advance and VTE outcomes continue to decline. Conducting the 
additional analysis would inform the providers and the organization if change has been 
sustained and hard wired into the daily workflow of the clinician. Reliable data collection 
and performance tracking is necessary for breakthrough and sustained levels of 
improvement (Maynard & Stein, 2010).  
 Another limitation of the quality improvement project is that the project focused 
only on THA cases. Orthopedic surgery is a well-established risk factor for VTE. 
Assessing total knee arthroplasty cases for the same time periods may provide additional 
insight into VTE ordering adherence and orthopedic VTE outcomes.        
Recommendations for Remediation of Limitations in Future Work 
 Based on the results of the DNP quality improvement project there are several 
recommendations for future doctoral work. The first opportunity is to conduct a 
retrospective analysis on the VTE cases that occurred during the pre and postelectronic 
order set time periods. The review may uncover risk factors that were missed that may 
have led to the development of a VTE or if appropriate prophylaxis was prescribed. The 
second opportunity is to integrate a VTE risk assessment and score into the electronic 
order set. Incorporating a VTE risk assessment into the electronic order set would provide 
transparency to nurses and other clinicians of the patient’s risk level and if the appropriate 
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prophylaxis was prescribed. Lastly, developing an educational campaign for nurses, 
patients, and families that VTE is an important and preventable public health concern is 
needed to raise awareness. Empowering patients and families to raise the issue of 
postoperative VTE with their providers may assist in preventing a negative outcome. 
Venous thromboembolism prophylaxis should be determined during the pre-operative 
surgical discussion with the provider and the patient. The information should accompany 
the patient upon arrival to the hospital and be reviewed again after the procedure. Patient 
knowledge and awareness may ensure consistent and reliable care processes in the 
prevention of VTE in the postoperative orthopedic patient.     
Analysis of Self 
As Practitioner 
 Throughout the development of the project, I became more knowledgeable of 
appropriate VTE prophylaxis for postoperative orthopedic patients and why orthopedic 
clinicians may be reluctant to ordering. I learned that key subject matter experts were not 
always familiar with recommendations from the literature and their practice may be 
lagging behind. In part, I believe this is because the guidelines are difficult to read and 
interpret. Often, there may be inconsistencies depending on who authored the content and 
this may lead to even more confusion and delays in implementing evidence-based 
practices. Simplifying the guideline content with application that is relevant to practice 
may assist clinicians in examining their current practice. The American Association of 
Colleges of Nursing (AACN, 2006) Essential VI, Interprofessional Collaboration for 
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Improving Patient and Population Health Outcomes holds competencies of effective 
communication and collaborative skills, analysis of complex practice issues, and 
consultative and leadership skills with interprofessional teams to create change in health 
care. The project has helped to further develop my communication and leadership skills. 
Taking time to understand why clinicians may be reluctant to change allowed me the 
opportunity to communicate and collaborate with them, which gave them confidence to 
use the electronic order set. I learned that clinicians are faced with many changes 
simultaneously and they need to have their voices heard or the changes risk being 
adopted and patients may have negative outcomes. The skills acquired throughout the 
DNP educational journey have prepared me to assess new evidence for integration into 
practice in a timely manner. The completion of the DNP project demonstrates the 
application of the DNP Essentials, which will provide the foundation for future advanced 
practice work.         
As Scholar 
 With the development of the project, I have gained expertise in navigating the 
organization’s complex health care system. Applying systems thinking at both the micro 
and macro levels enables the advanced-practice nurse to identify and implement new 
solutions to resolve practice issues (Zaccagnini & White, 2011). Conducting in depth 
literature reviews and presenting the information in a clear and succinct manner in the 
context of the organizational issue facilitated my development as a scholar. Becoming 
immersed in the evidence and citing relevant research studies has given me credibility 
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among the orthopedic surgeons and key stakeholders of the organization. Furthermore, 
the project provided a platform to incorporate DNP Essential III, Clinical Scholarship and 
Analytical Methods for Evidence-Based Practice, which holds competencies to evaluate 
quality improvement methodologies and the use of information technology to analyze 
data from practice (AACN, 2006). The competencies are evident through the evaluation 
of measuring VTE prophylaxis ordering adherence before and after implementation of 
the electronic order set. Designing a quality improvement methodology to assess ordering 
adherence has generated interest for orthopedic surgeons on their performance. The DNP 
project analyzed data from practice and patient outcomes by extracting data from the 
clinical information system and the electronic order set. The application of a scholarly 
approach to the DNP project will serve as the cornerstone for future quality improvement 
projects and research.       
As Project Manager 
 The DNP project facilitated my growth as a project manager. In this capacity, I 
learned how to take a project from concept through the steps of planning, designing, 
implementation and evaluation. In order to stay on track with the project timeline, I have 
learned to develop detailed project plans with key mile stone dates. I have also learned 
that it is important to recognize that other project members may not have the same time 
line in mind and this requires negotiation and compromise to meet the project 
deliverables. The project supported DNP Essential IV, Information Systems/Technology 
and Patient Care Technology for the Improvement and Transformation of Health Care, 
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which holds competencies to extract data from clinical informatics systems and monitor 
outcomes of care (AACN, 2006). The project leveraged the clinical information 
embedded analytics system to analyze differences in VTE prophylaxis ordering 
adherence and orthopedic VTE outcomes. I learned that when data is presented in a 
meaningful way that validates if protocols are followed, the orthopedic surgeons took 
notice and wanted to know who the outliers were. I learned that every key stakeholder is 
important to the project’s success. The project leader is responsible to regularly 
communicate the status of the project to key stakeholders. With the guidance of my 
mentor, I was successful in managing the project. 
Summary 
 The purpose of the project was to assess the difference of orthopedic VTE 
occurrences in the post-operative THA patient before and after implementation of the 
electronic order set. Analysis of the results indicated that after the electronic order set 
was implemented, VTE occurrences decreased from 10 of 325 or 3.08% to 3 of 406 or 
.74%. This represents a decrease of 2.34% in VTE occurrences for the pre and 
postelectronic order set time periods. Mechanical prophylaxis ordering adherence of 
100% was sustained both before and after the electronic order set was implemented. 
Pharmacological prophylaxis ordering adherence was increased by 2.7% from 86.5% to 
89.2% after the electronic order set was implemented. Based on these findings, 
technology with standard electronic order sets has had a positive influence on ordering 
adherence and reducing VTE outcomes.  
75 
   
 Completing the DNP project has been very rewarding and daunting. There were 
times when I was completely overwhelmed and wanted to give up. I questioned if I had 
enough intelligence, fortitude, patience, persistence, and tenacity to cross the finish line 
of the DNP program. I really struggled with writing the literature review portion of the 
paper. Deciphering the research studies was very challenging. I am glad that I persevered 
because I am able to discuss the evidence in a scholarly manner. I am grateful to Dr. 
Verklan for her guidance and support. Implementing conference calls every two weeks 
with Dr. Verklan kept me focused and on track. There were issues with the mapping of 
clinical data, which caused problems with data mining and extraction from the 
organization’s electronic health record. The organization’s CMIO was able to trouble 
shoot the mapping and remedy the issue. The lesson learned here is to expect the 
unexpected and be prepared for technological glitches because they will happen. 
 Overall, I am proud that I have made it to this point. Completing the DNP 
scholarly project will lay the foundation for future scholarly contributions to the nursing 
profession. It has inspired me to consider other projects for the orthopedic service line 
and preparing for the future of outpatient joint replacement. I am blessed with a 
wonderful family and network of close friends and colleagues that supported me and 
believed that I could become a Doctorate of Nursing Practice. I am looking forward to 
spending more time with my family and friends.         
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Section 5: Dissemination Plan 
 Nurses play a pivotal role in generating questions about safety and patient care. 
To improve patient care, it is necessary for nurses to develop advanced knowledge and 
skills to participate and lead teams that are pursuing best practices to improve patient care 
(Dearholt & Dang, 2012). Evidence-based practice and the nursing process are similar in 
that both are problem-solving strategies. As history has taught us, with innovation and 
major change come many challenges and golden opportunities for advancing nursing 
science, leadership, education, clinical practice and policy formulation, while optimizing 
organizational and nursing quality indicators, patient safety, and efficiency across 
systems of care (White & Dudley-Brown, 2012). Well-designed research and quality 
improvement projects provide one venue for showcasing the important contribution of 
nursing to major organizational change, improved quality, patient safety, efficiency, and 
overall effectiveness.  
There is a significant need for nurses to disseminate the findings of their evidence 
to determine if a practice change is effective. My dissemination plan is to present the 
findings in a PowerPoint presentation to the hospital organization study site’s orthopedic 
performance improvement team (PIT). The PIT team is a large interdisciplinary team 
comprised of organizational senior leaders, orthopedic surgeons, physician assistants, 
nurses, physical and occupational therapists, quality improvement specialists, discharge 
planners, pharmacists, and informatics nurses.  
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The next level of dissemination is to present a poster presentation at the 
organization’s nursing day of inquiry. The nursing day of inquiry is an annual event that 
was developed to support nurses’ translation of new scientific evidence into clinical 
practice. Nurses from across the health care system come together to share and 
disseminate the findings of their research and quality improvement projects. 
 Lastly, the next level of dissemination is to write a scholarly article for 
publication in a professional journal. At a later date, I will explore Computers, 
Informatics and Nursing (CIN) or The Journal of Arthroplasty as possible professional 
journals to publish in. A supplemental PowerPoint document will be provided, which 
details the plan to disseminate the scholarly work product.   
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